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“Imagination is more important than knowledge. For knowledge is limited to 
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Albert Einstein 
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IV. Zusammenfassung 
In eukaryotischen Zellen stellt Aktin das Protein mit der höchsten Abundanz dar, besitzt 
diverse Funktionen und ist Hauptbestandteil des Zytoskeletts. Daher spielt Aktin eine 
wichtige Rolle für die Entstehung und Erhaltung der Zell Form, der Zellmotilität, der 
Zelladhäsion, der Muskelkontraktion und der Zytokinese. Die Struktur des Aktinnetzwerks 
und seine zellulären Funktionen werden von Proteinen reguliert, welche allgemein als 
Aktin bindende Proteine (ABP) bekannt sind. 
Gegenstand dieser Arbeit war die Analyse eines neuen ABPs Synaptopodein 2 (SYNPO2) 
und seine Relevanz für die Phänotyp Modulation in vaskulären Glattmuskelzellen 
(vascular smooth muscle cell; VSMC). SYNPO2 ist maßgeblich an der Regulation von Aktin 
Nukleation und dem Umbau des Aktin Zytoskeletts beteiligt. SYNPO2 ist ein Dual-
Kompartiment Protein, welches seine subzelluläre Lokalisation zwischen dem Nukleus 
und dem Zytoplasma in Herz- und Skelettmuskelzellen ändert. Dieser Prozess geschieht in 
Abhängigkeit einer cyclischen Adenosinmonophosphats (cAMP)-abhängigen 
Phosphorylierung des SYNPO2 durch Protein kinase A (PKA) und Calcium/calmodulin-
dependent protein kinase II (CaMKII). Die unterschiedliche SYNPO2 Lokalisation spielt in 
vielen Prozessen, wie der Zelldifferenzierung, der Antwort auf Hitzeschock und unter 
pathophysiologischen Bedingungen, wie z. B. Blasen- und Prostatakrebs eine bedeutende 
Rolle. SYNPO2 wird abundant in VSMCs exprimiert, wobei seine Rolle in diesen Zellen 
jedoch bis jetzt unbekannt ist. 
In der vorliegenden Arbeit zeigen wir, dass der cAMP-abhängige PKA Signalweg am 
Pendeln von endogenem SYNPO2 zwischen Zellkern und Zytoplasma in beiden Richtungen 
beteiligt ist. Wie bereits beschrieben, konnten in Folge von erhöhtem cAMP eine 
Akkumulation von SYNPO2 im Zellkern detektieren werden. Des Weiteren legen wir dar, 
dass die Inhibierung der Protein Phosphatase 1 (PP1), der Protein Phosphatase 2A (PP2A) 
und/oder der Inhibierung von Phosphodiesterasen (PDEs) einen Einfluss auf die 
Anreicherung von SYNPO2 im Zellkern hat. Im Gegensatz zu Weins et al. 2001, die eine 
nukleäre Lokalisation von SYNPO2 in Folge eines Hitzeschocks zeigten, konnten wir nach 
einem Hitzeschock keine Veränderung in der Lokalisation des endogenen SYNPO2 
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feststellen. Zudem verursacht die Phänotypänderung der VSMCs nicht nur eine 
subzelluläre Lokalisationsänderung des endogenen SYNPO2, sondern beeinflusst auch 
dessen Expressionsrate. Kontraktile VSMCs (Tag 1) weisen eine starke Akkumulation von 
SYNPO2 im Zytoplasma auf, während nicht kontraktile (proliferative) VSMCs aus Passage 
3 eine starke Reduktion von zytoplasmatischem SYNPO2 und einen Anstieg von 
nukleärem SYNPO2 aufweisen. Wir konnten feststellen, dass die Aussaht von VSMCs 
(Passage 3) auf einer lamininbeschichteten Matrix zu einer Umkehrung des Phänotyps 
von nicht-kontraktil zu kontraktil und somit zu einer Akkumulation von SYNPO2 im 
Zytoplasma führt. Im Vergleich dazu, verbleiben VSMCs nach Aussaht auf Collagen I 
Beschichtung, im nicht-kontraktilen Zustand und weisen eine Akkumulation von SYNPO2 
im Nukleus auf. Interessanterweise wurde darüber hinaus eine Hochregulation von 
SYNPO2 im kontraktilen Phänotyp bei frisch isolierten VSMCs (Tag 1), als auch bei VSMCs, 
die auf Laminin kultiviert wurden, nachgewiesen. Um die subzelluläre Lokalisation von 
SYNPO2 und dessen Interaktion mit potentiellen Bindungspartnern zu analysieren wurde 
ein bimolekularer fluoreszenzkomplementations (bimolecular fluorescence 
complementation; BIFC) Ansatz etabliert. Es konnte eine Interaktion zwischen SYNPO2, 
14-3-3β und Importinα im Nukleus beobachtet werden, während SYNPO2 mit 14-3-3β 
ausschließlich im Zytoplasma interagiert. Diese Interaktion von SYNPO2 mit 14-3-3β 
wurde in Form von ‚nuclear bodies‘-ähnlichen Strukturen, welche nicht für den SYNPO2-
Importinα Komplex festgestellt werden konnte. Interessanterweise, formen beide 
Komplexe SYNPO2-14-3-3β und SYNPO2-Importinα ringförmige Strukturen. Zuletzt 
konnten wir zeigen, dass SYNPO2 Homodimere bildet, die hauptsächlich im Zytoplasma 
vorkommen. 
Zusammenfassend ist zu sagen, dass das neue Aktin bindende Protein SYNPO2 eine 
potentiell wichtige Rolle in mindestens drei Prozessen spielt, die mit einer 
Phänotypänderung einhergehen. Zum Ersten, während der Zelldifferenzierung und der 
vaskulären Entwicklung, des Weiteren für die Reparatur nach Gefäßverletzung und zuletzt 
unter pathologischen Umständen wie Arteriosklerose oder Krebs. Abschließend können 
wir sagen, dass SYNPO2, durch Aktin selbst und durch das Aktinnetzwerk vermittelte 
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Transkription, einen wesentlichen Teil zu der frühen und späten Differenzierung von 
VSMCs beiträgt. 
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Abstract 
In eukaryotic cells actin is the most abundant protein, forming different cytoskeletal 
structures and having different functions. Thus, actin plays a crucial role in processes such 
as the establishment of cellular shape, cell motility, cell adhesion, muscle contraction and 
cytokinesis. The structures of actin networks and their cellular functions are regulated by 
other proteins, generally known as actin binding proteins (ABPs).  
Subject of this work was the investigation of the novel ABP synaptopodin 2 (SYNPO2) and 
its relevance in vascular smooth muscle cell phenotype modulation. SYNPO2 is involved in 
the regulation of actin nucleation and remodeling of actin cytoskeleton. SYNPO2 is a dual 
compartment protein that alters its subcellular localization or shuttles between the cell 
nucleus and cytoplasm in cardiac and skeletal muscle cells depending on cAMP 
dependent kinases like protein kinase A (PKA), and calcium/Calmodulin- dependent 
kinase II (CaMKII). SYNPO2 shuttling occurs in several processes like differentiation, heat 
shock response, as well as under pathophysiological conditions, such as bladder and 
prostate cancer. SYNPO2 is abundantly expressed in VSMCs, whereas its functional role in 
these cells remains elusive. 
Our results demonstrate that the cAMP-mediated PKA pathway is involved in the 
shuttling of endogenous SYNPO2 between the cell nucleus and the cytoplasm in both 
directions. As described before, we detected that increased cAMP causes nuclear 
accumulation of SYNPO2 in VSMCs. Additionally, we show that inhibition of phosphatases 
like protein phosphatases 1 and 2A (PP1 and PP2A) and/or inhibition of 
phosphodiesterases (PDEs) affected the accumulation of SYNPO2 in the cytoplasm. 
Contrary to Weins et al. 2001, reporting a nuclear localization of GFP-myopodin upon 
heat schock, we did not detect any changes in the localization of endogenous SYNPO2 
due to heat shock. Furthermore, the phenotype switch of VSMCs not only causes an 
alteration of subcellular localization of endogenous SYNPO2 but it also affects its 
expression level. Contractile VSMCs (day one) showed a strong accumulation of SYNPO2 
in the cytoplasm, while non-contractile (proliferative) VSMCs from passage 3 displayed a 
strong reduction of cytoplasmic SYNPO2 and an increase in the number of cells with 
nuclear-localized SYNPO2. We observed that plating of VSMCs (passage 3) on laminin-
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coated matrices led to a back-switch from a synthetic phenotype to a contractile 
phenotype, which subsequently induces an accumulation of SYNPO2 in the cytoplasm. In 
contrast VSMCs plated on collagen I remain non-contractile, displaying nuclear 
accumulation of SYNPO2. Interestingly, we found an upregulation of SYNPO2 in the 
contractile phenotype of fresh isolated VSMCs (day one), as well as VSMCs (passage 3) 
grown on laminin. A new bimolecular fluorescence complementation (BIFC) based assay 
was established in order to analyze the subcellular localization and the interaction of 
SYNPO2 with its binding partners. An interaction between the SYNPO2, 14-3-3β, and 
importinα was detected in the nucleus, while SYNPO2 interacts with 14-3-3γ exclusively in 
the cytoplasm. The nuclear interaction of SYNPO2 with 14-3-3β was detected in form of 
nuclear bodies-like structures, which were not observed for the SYNPO2-importinα 
complexes. Interestingly, both SYNPO2-14-3-3β and SYNPO2-importinα complexes 
formed a loop-like structure. Finally, we show a self-association of SYNPO2 in the form 
homo-dimers mainly in the cytoplasm. 
Taken together, our findings indicate that the novel actin binding protein SYNPO2 plays a 
potential role in at least three different processes in which phenotype switch is essential, 
like during cell differentiation and vascular development, after vascular injury (vascular 
repair) and under pathological conditions like atherosclerosis, cancer. In summary, we 
may conclude that SYNPO2 is essential for early and late differentiation of VSMCs via 
mechanisms involving actin and actin-mediated transcription networks. 
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1 Introduction 
1.1 Muscle  
There are three types of muscle tissues in human and other vertebrates: skeletal, cardiac 
and smooth muscle. Skeletal muscles are the most abundant muscles in the body, which 
control and regulate positioning, and moving the skeleton, while cardiac muscle is only 
present in the heart and is responsible for blood streaming in the vascular system. 
Smooth muscles are found in various internal organs like stomach, urethra, and blood 
vessels. 
1.1.1 Vascular smooth muscle 
By using light microscopy, we are able to see differences between smooth muscle cells 
(SMCs) and skeletal muscles. In skeletal muscle, the arrangement of actin and myosin 
filaments cause a myofibrilar striated structure while in smooth muscle cells appear 
homogeneous. This difference can be explained by morphological differences of the 
individual muscle fibers between the skeletal muscle and SMCs. In the muscle fibers of 
skeletal muscle, the contractile elements like myofibrils are arranged in parallel, which 
showing a longitudinal view of bundles. However, in smooth muscle, the myofilaments 
form a cross-linked structure within the cells. Furthermore, SMCs contain actin as much 
as skeletal muscle cells per unit of cell volume, but five times less myosin1-3. The SMCs are 
spindle-shaped with a factor of 20 smaller than skeletal muscle cells (Fig. 1).  
 
 
 
 
 
 
 
 
 
 
Fig. 1 Schematic illustration of (A) skeletal and (B) smooth muscles (according to Lodish 4th Ed). 
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The single nucleus of SMCs is centrally located in the cell, while in the multinucleated 
skeletal muscle cells, the nucleus are located directly at the periphery of the cell (Fig. 1). 
In smooth muscle, the actin filaments are anchored to the cell membrane by the dense 
plaques and intracellular to the dense bodies via an actin binding protein known as α-
actinin. Dense plaques and dense bodies contain α-actinin and vinculin, and they are 
therefore considered to be equivalent to the Z-discs of skeletal muscle. Based on the size 
of the protein structures, three types of filaments can be distinguished in the smooth 
muscles as follows: (A) The thin filaments having a diameter of Ø 5-8 nm consist mainly of 
filamentous actin, tropomyosin and actin-binding proteins, for example, caldesmon. 
These thin filaments form together with (B) the thick myosin filaments (Ø 16 nm) the 
contractile apparatus of SMCs. Furthermore, actin filaments are connected with (C) 
intermediate filaments (Ø 10 nm) by adapter proteins. Intermediate filaments are a part 
of the cytoskeleton, which are not involved in the contraction of muscles, but have 
structural functions. Desmin and vimentin are two abundant intermediate filaments 
proteins in smooth muscle4.  
SMCs can be functionally divided into two types, which in turn can perform different 
functions.  
 The "multi-unit" type, which is usually stimulated vegetatively, and this type is 
without spontaneous activity. They mainly occur in blood vessels with a larger 
diameter and the bronchi. 
 The "single-unit" type is of the hollow organs of the gastrointestinal tract (GI 
track), in which the SMCs are connected via gap junctions. They can almost 
simultaneously contract together and demonstrate a rhythmic activity of 
spontaneously active pacemaker cells. 
Smooth muscles can be further distinguished in phasic and tonic contractile smooth 
muscle. Phasic contraction underlies the rhythmic contractions of for instance, the 
intestine, the portal vein and the ureter. Tonic contractions occur in most blood vessels, 
the trachea, and in the sphingters of the gastrointestinal tract5. The vascular smooth 
muscle cells are a main component of the vascular system like blood vessels, which 
regulate vessel tone, blood pressure and distribution of blood flow in the vascular system 
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like arteries, veins and capillaries6, 7. The vascular smooth muscle cells control and/or 
regulate blood stream through the vessels by contraction and relaxation, and therefore 
changes in the vessel volume8, 9. In the mature vessels, smooth muscle cells are mainly in 
the contractile state (also known as differentiated) and have an extremely low non-
contractile phenotype8, 10. However, unlike skeletal muscle and cardiac cells, SMCs retain 
remarkable plasticity and can therefore change their phenotype during different 
pathophysiological conditions6, 10-13.  
 
1.1.2 Molecular basis of contraction and relaxation 
To analyze and to comprehend the function of smooth muscle cells in normal 
physiological conditions and in diseases, it is not easy without a complex study about 
cellular events, extracellular matrix components and their interactions together and with 
membrane components. The general principle of contractility of SMCs is the same as that 
described for skeletal muscle depends on ATP/ADP exchanges. Each myosin protein head 
possesses ATPase activity and controls its binding to actin in a cyclical manner that 
couples ATP binding and its hydrolysis into ADP and inorganic phosphate (Pi) to a 
conformational change in the myosin head14, 15. 
In absence of ATP, the head of the heavy chains of myosin binds tightly to actin. Briefly, 
after binding of ATP, the myosin head can detach from the actin whereas the ATP is 
hydrolytically cleaved into ADP and Pi. The cleavage products initially remain on myosin, 
while myosin is weakly bound to actin. Only the sequential release of Pi and ADP leads to 
the formation of strongly bound myosin to actin, force-generating cross-bridges, 
conformational changes in the area of myosin heads and therefore the so-called "Power 
stroke", which finally causes the shortening of sarcomeres and thus the whole muscle14, 
15.  
Fig. 2 illustrates a general signaling that regulates the smooth muscle contractile 
machinery depending on both Ca2+ and GTPase protein signaling16. Regulation of smooth 
muscle cell tone is mainly depends on calcium concentration and Ca2+ sensitization and 
desensitization, which in turn are regulated by various agonists bind to the specific 
receptors and in the subsequent activation of the SMCs contraction mechanism17, 18. An 
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increase in the intracellular Ca2+ concentration, in response to a wide spectrum of 
extracellular signals, activates Ca2+-Calmodulin depended myosin light chain kinase 
(MLCK), and subsequent phosphorylation of the regulatory light chain of myosin (MLC20) 
at serine 19, which is the main regulatory mechanism in activating smooth muscle cell 
contraction18-20. In contrast to contraction, relaxation is initiated by dephosphorylation of 
MLC20 by myosin light chain phosphates (MLCP). MLCP belongs to the family of 
hydrolases and is a heterotrimer of three subunits: a PP1c catalytic subunit, a 20-kDa 
subunit of unknown function, and a regulatory subunit, myosin phosphatase type 1 
(MYPT1), which targets MLCP to myosin18 (Fig. 2). 
In addition, G proteins increase Ca2+ sensitivity and therefore contractility in the smooth 
muscle cells due to the inhibition of MLCP21-23. Further studies demonstrated that this 
inhibition is controlled by the phosphorylation state of MYPT124, 25. Moreover, several 
groups reported that GTPase-induced Ca2+-sensitivity and therefore contractility of SMCs 
is based on the activation of Rho and Rho-associated protein kinase (ROCK) signaling 
pathways, in which ROCK inhibits MLCP by phosphorylation26-31.  
 
  
 
 
 
 
 
 
 
 
Fig. 2 Schematic illustration of the signals that regulate and control the smooth muscle cell contraction and 
relaxation (according to Puetz et al 2009)16. 
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1.1.3 Smooth muscle cells phenotype plasticity and disease 
SMCs in the vascular system and other systems in adult animals are differentiated cells, 
whose principal function are the contraction and regulation of blood vessel tone, blood 
pressure, and blood flow7, 8, 10, 32. Notably, unlike other cells that are terminally 
differentiated, smooth muscle cells retain their ability to change their phenotype from a 
contractile to a non-contractile phenotype (synthetic phenotype) and vice versa according 
to the physiological and pathophysiological conditions10, 11, 13, 33. The phenotype plasticity 
of SMCs (also known as phenotype modulation) plays a crucial role during vascular 
development, regulation of the vascular system (vascular remodeling) during blood flow, 
blood pressure, and also during diseases such as injuries, atherosclerosis, cancer, and 
diabetes10-12, 34-39. SMCs in a differentiated state express a variety of contractile proteins 
and contractile-associated marker proteins that regulate and control the correct function 
of these cells. In other words, in mature vessels contractile or differentiated SMCs are 
characterized by the expression of marker proteins such as smooth muscle α-actin 
(αSMA), smooth muscle myosin heavy chain (smMHC), calponin, h-caldesmon, SM2240, 41, 
and smoothelin42-44. Consequently, many studies have also shown that up and/or down 
regulation of these proteins are correlated by phenotype modulation of VSMCs and 
diseases45-47. For instance, upon injury, VSMCs dedifferentiate into non-contractile 
smooth muscle cells, with an increased rate of proliferation, migration and also synthesis 
of extra cellular matrix components13, 48, while at the same time VSMCs showed a 
reduction in expression levels of marker proteins12, 41.  
Many groups reported specific factors and regulatory pathways, which directly or 
indirectly promote and control SMCs phenotype modulation during cellular processes and 
diseases8, 10, 11, 32. Tacking together, these results suggested that the phenotype 
modulation plays a crucial role in vascular development10, 49 and repair of vascular 
diseases like injury36, 37. Furthermore, the model that has evolved in the last years for the 
regulation and controlling of VSMCs phenotype modulation is extremely complex. It 
depends on environmental cues, signaling pathways that control expression of genes 
characteristic for VSMCs. Therefore, we are just beginning to understand some of the 
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molecular mechanisms that control phenotype modulation of VSMCs during 
pathophysiological conditions.  
 
1.1.4 Actin cytoskeleton 
1.1.4.1 Actin and actin filaments 
Actin is the most abundant protein in eukaryotic cells (up to 20% of the total protein)50, 51. 
It is a highly conserved protein family with six different actin proteins that is divided into 
three isoforms: 3 α-, 1 β-, 2 γ, which are tissue specific52. Alpha actins are found in muscle 
(α-skeletal, α-aortic smooth, α-cardiac), and γ2-enteric smooth, whereas β and γ isoforms 
are dominant in non-muscle cells. Smooth muscle α-actin is mainly expressed in vascular 
smooth muscle53, whereas in visceral smooth muscle, a high proportion of γ-actin is 
found. The β-isoform of actin is expressed in all smooth muscle tissues and appears to be 
a component of the cytoskeleton54. Actin, as a major component in cytoskeleton, is the 
best investigated protein in motility systems, and regulation of mechanical and 
biomechanical signals through the cells. However, its exact functions in different 
pathophysiological conditions, development, aging and diseases are not completely 
understood. Actin exists in two forms, monomeric, G-actin with a molecular mass of 42 
kDa and filamentous, F-actin.  
Actin, as an involved protein in the cell movements, controls contraction/relaxation 
mechanism by two actions: A) actin polymerization and depolymerization and B) 
interaction with motor proteins like myosin family. The average length of actin filaments 
in the contractile state of VSMCs is about 4.5 µm, whereas myosin filament length is only 
1.6 µm 1, 54, 55. Actin filaments, Actin binding proteins (ABPs), myosin and other proteins 
that interact with the actin cytoskeleton, make stress fibers in the cells50, 56, 57, which are 
dominant in cell culture conditions57. The actin cytoskeleton contains two types of 
filaments, cross-linked filaments and cortical actin filaments50. Cross-linked filaments 
control cytoskeletal deformation, transmit forces and stabilize subcellular localization of 
cellular organelles, while cortical filaments stabilize the form of cells during different 
physiological conditions, cellular development and inhibit lateral movement of organelles 
in the cells50, 56.  
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Actin filaments extend when ATP-G-actin monomers bind to the barbed end, while actin 
filaments disassemble when ADP-G-actin monomers lose from the pointed end58-60 (Fig. 
3). Actin filaments are highly dynamic and their elongation involves both polymerization 
and depolymerization61-63. The polymerization of actin filaments occurs in three 
sequential steps: (A) nucleation step, (B) elongation step, and (C) steady state step61, 64. 
The first step (A) initiates with the formation of a trimer of G-actin monomers that is also 
known as a polymerization nucleus, which in the second step (B) will be used 
to elongate a filament by the addition of actin monomers to both of its ends. Finally, as 
actin filaments grow, (C) the concentration of G-actin monomers decreases until it 
reaches a steady state with the F-actin filaments (critical concentration) that are 
important to control assembly and disassembly of actin monomers56, 64, 65. With this 
notion that both the formation of a stable actin trimer as the initial point for 
polymerization and elongation are dependent on the critical concentration of monomers, 
dynamics of this concentration play a major role in assembly and disassembly processes. 
Actin nucleation and Cc therefore require additional proteins known as 'actin binding 
proteins' that control and/or regulate the formation of a stable actin nucleus and Cc in 
the cells. Beside actin, actin binding proteins are the other abundant protein super family, 
which account for 10% of total cellular protein56. For instance, the Arp2/3 
complex66, formins67, 68, and synaptopodin 2 (SYNPO2) as a novel actin protein regulate 
nucleation of actin and ADF/cofilin69, 70 disassembles actin filaments. While the function 
of actin nucleators such as the Arp2/3 complex65, 71, and formins has been extensively 
studied in cells, the role of SYNPO2 is not completely clear. The detailed biochemistry and 
function of the synaptopodin family on the actin dynamics is under investigation. Further 
detail about the synaptopodin family is discussed in the next section.   
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Fig. 3 Schematic illustration of actin polymerization/depolymerization. ADP binds with ~10-fold lower 
affinity to the nucleotide binding site of Mg-G-actin and ~200-fold weaker to the Ca-G-actin monomers as 
compared to the ATP and ADP-Pi, which is crucial for actin polymerization and depolymerization
60. 
1.2 Synaptopodin family  
As described above, the functions of actin and the actin cytoskeleton are regulated 
or/and controlled during a variety of cellular processes which are involved in different 
pathophysiological conditions by ABPs50, 56, 72. The synaptopodin family comprises a 
conserved family of proteins that fall into three different members; Synaptopodin, 
Synaptopodin 2 (SYNPO2), and Synaptopodin 2 like proteins (SYNPO2l), which are also 
divided by different splicing in various isoforms73. The main feature of the synaptopodin 
family seems to be the natively unfolded form of these proteins, which is supposed to be 
necessary for their potential functions in the cells. Accordingly, the synaptopodin family 
may have different binding partners73. Although different genes, located on different 
chromosomes, express synaptopodin proteins they show a high similarity73. The 
intrinsically unfolded structure of the synaptopodin family members depends on position 
and/or the high proline content. 
Since their discovery, the synaptopodin family members have been studied in different 
cell types. The synaptopodin family members play various roles in spine motility74, actin 
organization75, 76, cell differentiation77, cancer78-80, and heart development and 
somitogenesis81, 82. The detailed biochemistry and function of synaptopodin family is 
discussed in the following sections. 
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1.2.1 Synaptopodin 
Synaptopodin (SYNPO) as the first member of the synaptopodin family was reported by 
Mundel et al. in 1997 as a novel actin binding protein which expresses in both 
differentiated kidney podocytes, associated with the actin cytoskeleton of postsynaptic 
densities, and in telencephalic synapses of the brain, associated with dendritic spines74, 83. 
Synaptopodin is expressed by the gene SYNPO, located on chromosome 5 (human). 
Synaptopodin binds either directly to F-actin and α-actinin on several independent 
binding sites84 or indirectly to F-actin via binding to α-actinin85. At this time, the published 
human protein sequence included a 685-aa polypeptide with a calculated molecular mass 
of 73.7 kDa and an isoelectric point of 9.38. The appropriate murine homolog showed a 
690-aa protein with a calculated molecular mass of 74.0 kDa and an isoelectric point of 
9.27. In SDS-PAGEs SYNPO2 migrated with an app. molecular mass of 100 kDa. A 
sequence analysis showed a 84% sequence similarity between the human and murine 
synaptopodin. Furthermore, 2005 the Mundel group reported85, that murine 
synaptopodin includes three splice variants that are tissue-specific, short-variant (685 
amino acids) neuronal, long-variant (903 amino acids) and variant T (181 amino acids) 
renal. Functional analysis demonstrated that synaptopodin caused a connection between 
the actin cytoskeleton and spine apparatuses of telencephalic neurons86, which may 
suggest a crucial role for synaptopodin in case of regulation of long-term potentiation 
(LTP). Further anaylsis showed that the lack of synpatopodin in synpo-/- mice caused a 
complete lack of spine apparatuses and in turn a loss of LTP and learning impairments87.  
 
1.2.2 Synaptopodin 2 
The novel actin binding protein synaptopodin 273, 75 (known as myopodin77 or fesselin88) 
regulates actin nucleation and polymerization in a Ca2+-Calmodulin manner89-91. SYNPO2 
is expressed by the gene SYNPO2, located on chromosome 4 (human). Sequence analysis 
of SYNPO2 demonstrated a 47% amino acid similarity to synaptopodin. De Gank reported 
in 2008 three different isoforms which seem to be a result of different splicing events79, 
however Chalovich and Schroeter reported in 2010, 5 isoforms of SYNPO2 (Fig. 4 ). 
SYNPO2 binds directly to F-actin and α-actinin at several binding sites92, 93. 
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Fig. 4 Schematic illustration of synaptopodin 2 isoforms in human. 
 
SYNPO2 is a tumor suppressor protein80, 94, 95 and shuttles between the nucleus and the 
cytoplasm during differentiation and under stress such as heat shock77, 96. The suppressor 
activity of synaptopodin 2 on cell growth and cell motility seems to be dependent on 
phosphorylation and interaction of myopodin by/with integrin-linked kinases95. It has 
been shown that the differentiation of myoblasts to myotubes affects translocation of 
SYNPO2 from the nucleus to the cytoplasm77. In smooth muscle cells SYNPO2 is expressed 
in the cytoplasm where it is localized in dense bodies97 (and Z-disc in striated muscle77, 93). 
Additionally it has been observed that SYNPO2 accumulated in the cell cytoplasm during 
tumor development and metastases79, 80, 94. Notably, loss of nuclear myopodin is 
connected to the clinical outcome94. However, its exact function is still unclear and under 
intensive investigation.  
Detailed analyses of the biochemical and biophysical properties of SYNPO2 from turkey 
gizzards showed that it can control critical functions of actin, such as nucleation and 
elongation of monomeric G-actin as well as bundling and crosslinking of F-actin 
filaments73, 75, 90, 98. A further link to the actin cytoskeleton is established by the ability of 
SYNPO2 to bind to myosin76, α-actinin93, 99, and filamin93. The binding to α-actinin is 
important for the regulation of the transport of SYNPO2 to the nucleus, which was 
observed in C2C12 cells and cardiac myocytes93, 100. This shuttle has been observed after 
the application of heat shock77, 96, upon which murine SYNPO2 is phosphorylated by 
protein kinase A (PKA) and Ca2+-calmodulin dependent kinase II (CaMK II)100. This 
posttranslational phosphorylation releases SYNPO2 from α-actinin and induces the 
P a g e  | 28 Introduction 
binding of SYNPO2 to the 14-3-3 protein100-102. Binding of SYNPO2 to 14-3-3 requires the 
presence of two 14-3-3 binding motifs73, 100, 101. Afterwards the 14-3-3-SYNPO2-complex 
binds to the protein importin-α, and shuttles to the nucleus96, 100-102. 
Interestingly, the human SYNPO2 provides only one 14-3-3 binding motif, the required 
second motif is missing. Therefore, the mechanism by which SYNPO2 is translocated to 
the nucleus of human cells is still unclear. 
 
1.2.3 Synaptopodin 2-like 
The synaptopodin 2-like protein also known as cytoskeletal heart-enriched actin-
associated protein (CHAP) or tritopodin is the third member of the synaptopodin family81, 
103. A gene (SYNPO2L) located on chromosome 10 in human expresses CHAP protein. 
CHAP is a new Z-disc protein that is expressed in differentiated heart, skeletal muscle 
during embryonic development81 and in adult aorta, carotid and coronary arteries in 
vascular smooth muscle cells, but not during embryonic development82. This protein 
exhibits approximately 31% similarity to SYNPO2 and 30% to synaptopodin. This sequence 
similarity may suggest similar features for CHAPs81, 82. Beqqali reported two isoforms of 
murine CHAP (mCHAP) that are produced by alternative splicing. CHAPa resulted from 
exons 1, 2, 3, and 5 and has a molecular weight about 140 kDa, while CHAPb started with 
a start-codon in exon 4 and produced a protein with 110 kDa. A sequence analysis of both 
isoforms showed a classical NLS sequence (KKRR) for both CHAPa and CHAPb and a PDZ 
domain for CHAPa. However, this NLS was not crucial for nuclear import of mCHAP. A 
protein expression analysis of different isoforms showed that CHAPb was only expressed 
during early skeletal muscle and heart development, while the long isoform CHAPa was 
expressed around day E 17.5 and a high level of CHAPa protein was detected in adult 
heart and skeletal muscle, whereas CHAPb protein was undetectable. 
Immunofluorescence studies demonstrated a low nuclear localization and a strong 
colocalization of mCHAP proteins and α-actinin within the Z-discs in the sarcomers of 
embryonic cardio myocytes. Although, CHAP contains a C-terminal actin-binding domain, 
it interacts with actin via binding to α-actinin. Zebra fish studies using antisense 
morpholino oligonucleotides demonstrated a crucial role of CHAP during heart 
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development and somitogenesis. Downregulation of CHAP in zebra fish caused 
dysfunction of cardiac contractility, myofibrillar disarray, disruption of somite boundaries, 
sarcomeric integrity and notably muscle defects in case of the contraction.  
 
1.3 Protein-Protein interaction 
All cellular processes, including development, pathophysiological conditions and diseases 
are controlled by signaling pathways, which in turn are based on protein-protein 
interactions. Correct localization of proteins, protein-protein interactions and their 
dynamic at the plasma membrane and along the signaling cascade play important roles in 
cell signal transductions49, 104, 105. Although, many biochemical techniques like 
immunoprecipitation, pull-down assay, yeast two-hybrid and other in vitro assays 
elucidated many details about protein-protein interactions, the existence of protein 
complexes and their physiological roles in living cells is of greater interest, especially in 
cases of diseases and development studies106, 107. Despite the evidences and results from 
biochemical methods, there are many details about the exact roles and functions of 
proteins that remain unclear.  
To investigate the existence of protein complexes and in turn also their physiological roles 
in cells, the methods often rely on Fluorescent tagged proteins and therefore 
conventional fluorescence imaging methods to detect the distribution and/or protein-
protein interaction in a cellular context108-110. Due to their sensitivity and selectivity, 
fluorescence imaging techniques like fluorescence and confocal microscopy stand out 
among the other optical techniques used in characterization of structures, detection and 
quantification of processes like protein-protein interaction109-112. Notably, these 
techniques provide useful information on diversity of process and involved proteins that 
can be related to their physiological functions. Regarding to these evidences, förster 
resonance energy transfer (FRET) and more recently bimolecular fluorescence 
complementation assay, BIFC, are two powerful assays that facilitate and realize live 
imaging of protein interactions in the cellular context. It has been recently reported that 
14-3-3 proteins as chaperone-like adaptor proteins are able to bind a specific sequence of 
SYNPO2101, which in turn is crucial for the interaction of importinα with NLSs of SYNPO2 
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and its shuttling from the cell cytoplasm to the nucleus96, 101. This synergy strongly 
depends on the phosphorylation form of SYNPO2 as shown by in vitro experiments100. 
Nevertheless, this evidence waited for more physiological information about these 
proteins in the cellular context. 
We will use specific techniques that should allow us to analyze the interaction between 
SYNPO2, 14-3-3 and importinα in a cellular context. In this way we will be able to increase 
our understanding of both the basic mechanisms of interaction between SYNPO2, 14-3-3 
and importinα in cells and also how this interaction controls subcellular distribution of 
SYNPO2.  
 
1.3.1 Förster resonance energy transfer 
FRET is a commonly used method to investigate molecular dynamics in biochemistry113, 
protein-DNA interactions114, protein-protein interactions, and protein conformation 
changes115 in both in vitro and in vivo116-118. It is describing an energy transfer between 
two fluorescent (fluorophores) that are tagged to proteins of interest. Notably, the 
introduction of fluorescent proteins like GFP and GFP variants revolutionized one more 
time the use of this method for protein-protein interaction studies and the study of 
protein conformational changes in cellular context116, 119. In principle, FRET occurs when 
emission and absorption spectra of two different chromophores, usually two green 
fluorescent protein variants, overlapped. However, this is only achieved if two 
chromophores fused to two different proteins or two different sites of one protein, which 
it becomes a distance range between 10-80 Å according to the conformational changes of 
protein or the interaction of two proteins (Fig. 5). Combination of fluorescent conjugated 
proteins and FRET assay offer a unique chance to visualize and to monitor a real-time 
protein-protein interaction, conformational changes, and localization studies of proteins 
in living cells117, 118, 120, 121. 
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Fig. 5 Principle of FRET assay used in vivo. Two fluorescent fusion proteins were used to perform FRET 
measurements with CFP as a donor and YFP as an acceptor. FRET occurs as a non-radioactive energy 
transfer between two fluorophores, in which the excitation of the donor induces an energy transfer from 
the donor to the acceptor resulting in the reduction of the donor and an increase of acceptor fluorescence. 
The critical point is 10 nm distance.  
 
1.3.2 Bimolecular fluorescence complementation (BIFC) 
Although, FRET is a powerful method for colocalization and protein-protein interaction 
studies of the fluorescent conjugated proteins, its limitations include the crucial distance 
~ 10 nm, and choice of the best sites for ligation of fluorescent proteins (chromophores) 
that may lead to false-positive or -negative, remains a significant challenge117, 122. For 
instance, false-negative can occur when the distance between two Fluorescent labeled 
components in large protein complexes is too far. Therefore optimizing and characterizing 
the best FRET constructs can be time-consuming. The second technique, known as 
bimolecular fluorescence complementation (BIFC), is an alternative method that 
eliminates these limitations in case of distance and false negative123, 124. Notably, this 
method offers a simultaneous visualization of multiple protein interaction in living cells125, 
126. It is based on fluorescence development, according to complementation of two non-
fluorescent fragments when they associate together by the interaction between 
interested proteins fused to each fragment123, 127. Therefore, the reconstitution of the 
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fluorescent protein is activated by the direct interaction between the two target proteins. 
Since BIFC introduction, different BIFC-based assays have been developed and used in a 
cellular context. For instance, BIFC was used to visualize the molecular mechanism of 
protein-protein interaction in living cells128, protein dimerization/oligomerization, protein 
ternary complex formation129.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Schematic illustration of the BIFC assay used in this work according to Hu, CD. et al. 2003 130. BIFC 
fluorescence development is based on the interaction between protein A (14-3-3) and protein B (SYNPO2) 
in a cellular context.  
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1.4 Aim of the project 
Vascular smooth muscle cell (VSMC) modulation is essential during vascular development, 
contributes to the vascular lesion formation and plays an essential role in diseases such as 
atherosclerosis, post-angioplasty restenosis and also during vascular repair. The 
mechanisms regulating the modulation of this cell type are therefore of great interest. 
Several studies have shown that alterations in the function and/or expression level of 
contractile and cytoskeletal proteins are associated with VSMCs modulation. Moreover, 
several studies have revealed that actin is associated with phenotype modulation of 
VSMCs. The structures of actin networks and their cellular functions are regulated by 
other proteins, generally known as actin binding proteins (ABPs). One novel class of such 
proteins is synaptopodin 2 (SYNPO2), of which there are at least five isoforms. 
The functional features and significant roles of SYNPO2 in VSMCs, characterized by an 
abundant expression of SYNPO2, are so far unknown. 
The purpose of this work is to find out (A) the consequences of the VSMCs phenotype 
switch on the subcellular distribution of SYNPO2, (B) whether SYNPO2 plays an active role 
in this process, (C) whether cAMP dependent signaling pathways like PKA, are required 
for SYNPO2 trafficking in VSMCs, and finally (D) to investigate the molecular mechanism 
of SYNPO2’s shuttling by using biophysical techniques such BIFC and FACS-BIFC assay in a 
cellular context. 
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2 Materials and Methods 
 
2.1 General materials 
In this work, the materials and reagents were purchased from Qiagen, New England Bio-
Lab, Sigma Aldrich, Merck, Invitrogen, and Roth. Sequencing of DNA fragments were 
performed by MWG. Primers were designed with snap-gene viewer software and ordered 
form Invitrogen and MWG.  
CHEMICALs 
Table 1 All chemicals used in this work. 
NAME PROVIDER 
3-Isobutyl-1-methylxanthin (IBMX) Sigma-Aldrich 
Acrylamide/Bisacrylamide AppliChem 
Agarose Sigma-Aldrich 
Ammonium peroxodisulfate (APS) Serva  
Ammonium sulfate AppliChem  
Ampicillin AppliChem 
β-mercaptoethanole Serva 
Bacto-agar  Roth 
Bacto-tryptone  Sigma-Aldrich 
BCA reagents  Pierce 
Bradford reagent  BioRad 
Chloramphenicol  Roth 
Collagenase I, II Worthington 
Collagen I Upstate 
Complete protease inhibitor cocktail  Roche 
Coomassie Brilliant Blue BioMol Feinchem. GmbH 
Cover Slip Mounting Medium  Poly Science 
Dimethyl sulfoxide (DMSO)  Sigma-Aldrich 
P a g e  | 35 Materials and Methods 
Dried milk powder (fat free)  AppliChem 
Dithiothreitol (DTT) AppliChem 
ECL Cell Attachment Matrix Millipore 
Ethylenediaminetetraacetic acid disodium 
salt Dehydrate (EDTA)  
Sigma-Aldrich 
Ethanol (absolute p.a.)  J.T. Baker 
Fetal Bovin Serum Sigma-Aldrich 
Formaldehyde  Sigma-Aldrich 
Forskolin Tocris 
Fungicide Gibco 
Glutathione  Roth 
Glycerol  Sigma-Aldrich 
H89 Tocris 
Hank's Balanced Salt Solution (HBSS) Gibco 
HCl  J.T. Baker 
HEPES Gerbu Biotechnik GmbH  
Hoechst 33342 Sigma 
Isopropyl-thio-β-d-galactoside (IPTG)  Roth 
Isopropanol Roth 
Kanamycin Gerbu 
Leptomycin B (LMB) Santa Cruz 
LB-Agar Roth 
LB-Medium Roth 
L-Glutamine 200mM Gibco 
Kanamycin AppliChem 
KCl Sigma-Aldrich 
KH2PO4 Sigma-Aldrich 
K2HPO4 Sigma-Aldrich 
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Laminin I Sigma-Aldrich, L2020 
Methanol (absolute p.a.) J.T. Baker 
MgCl2 Sigma-Aldrich 
N2 (liquid) Air Liquid 
NaCl J.T. Baker 
NaHCO3 Sigma-Aldrich 
NaH2PO4 Sigma-Aldrich 
Na2HPO4 Sigma-Aldrich 
NaN3 Sigma-Aldrich 
NaOH J.T. Baker 
NP-40 AppliChem 
Paraformaldehyde (PFA) Sigma 
Penicillin Streptomycin (Pen Strep) Invitrogen 
Phalloidin Invitrogen 
Phosphate buffered saline (PBS) Invitrogen 
Phenylmethylsulfonyl fluoride (PMSF) Sigma-Aldrich 
Polyacrylamide Roth 
Ponceau S Sigma 
Sodium dodecyl sulfate (SDS) AppliChem 
Tetramethylethylen di amine (TEMED) Serva  
Trypsin-EDTA Solution (1x) 0.05% Gibco 
Tryptone MP Biomedicals 
Tris Roth 
Triton-X100 Sigma-Aldrich 
Tween-20 Calbiochem 
Trypan blue Sigma-Aldrich 
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KITs AND MATERIALs 
Table 2 List of Kits and Materials 
KIT PROVIDER 
10 cm dishes for Agar Plates BD Biosciences 
BCA Protein Assay Kit Pierce/Thermo Scientific 
Cell culture dishes (10 cm) BD Biosciences 
Cell culture dishes (6 cm) BD Biosciences 
Cell culture dishes (24-well) BD Biosciences 
Cell culture dishes (12-well) BD Biosciences 
Cell culture dishes (6-well) BD Biosciences 
Cover glass 10 mm VWR 
Cover glass 12 mm VWR 
G-Actin/F-actin In Vivo Assay Biochem Kit Cytoskeleton 
Gel Purification Kit Qiagen 
GoTaq® qPCR MasterMix Promega 
Maxwell Simply RNA  Promega 
Micro-Amp Fast 96-Well Reaction Plate (0.1 ml) Invitrogen 
Mini-Prep PeqLab,Qiagen 
Micro tubes (1.5 ml) Eppendorf 
Micro tubes (2 ml) Eppendorf 
PCR Purification Kit Qiagen 
PCR Soft-tubes 0.2 ml clear Biozym 
Stripettes 5, 10, 25 (ml) Falcon 
Tube 15, 50 (ml) Falcon 
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BUFFERs AND SOLUTIONs 
Table 3 All buffers and solutions used in this PhD work 
NAME INGREDIENT APPLICATION 
Blocking Solution 
5 % (w/v) non-fat milk 
powder in 1X TBS or TBST 
Western Blot 
Blocking Solution 
5 % (w/v) BSA powder in 1X 
PBS 
Immunofluorecence 
CELL LYSIS BUFFER (RIPA) 
25 mM Tris, pH 7.4, 137 
mM NaCl, 50 µM EDTA, 1% 
Triton X100, 0.5% sodium 
deoxycholat, 0.1% SDS, 1 
mM PMSF, 1X PIC 
Mammalian cell 
Coomassie Stock Solution 
755 mM (NH4)2SO4 
2.55% (v/v) Phosphoric acid 
0.1% (w/v) Coomassie 
brilliant blue G- 
250 
SDS-PAGE (Protein 
analysis) 
Coomassie Solution 
80% Coomassie Stock 
Solution 
20% (v/v) Methanol 
SDS-PAGE (Protein 
analysis) 
HEPES-buffered saline (HBS) 
2X 
 
50 mM HEPES 
280 mM NaCl 
1.5 mM Na2HPO4 
Transfection 
PFA FIXATION SOLUTION 
4 % (w/v) Formaldehyde in 
1X PBS pH 7.5 
Immunofluorescence 
study 
PBS 
2.7 mM KCl 
1.7 mM NaH2PO4 
10 mM Na2HPO4 
Protein isolation, western 
blot, and cell culture 
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137 mM NaCl, pH 7.5 
SDS-loading buffer (2X) 
8 M Urea, 100 mM Tris-HCl, 
pH 6.8, 2% SDS (w/v), 0.2% 
bromophenol blue, 20 mM 
DTT, 1 mM PMSF, 1X PIC 
Visualization of proteins 
by SDS-PAGE 
SDS-Separation buffer (4X) 
1.5 M Tris, pH 8.8 
0.4% (w/v) SDS 
SDS-PAGE 
SDS-Running buffer (10X) 
250 mM Tris, 1.92 M 
glycine, 1% SDS 
SDS-PAGE 
TAE buffer (1X) 
40 mM Tris acetate, 
2 mM EDTA,  
pH 8 
 
TBS 
150 mM NaCl 
10 mM Tris, pH 7.5 
Western blot 
TBST 
150 mM NaCl 
10 mM Tris, pH 7.5 
0.01% Tween 20 
Western blot 
Western blot running buffer 
(1X) 
25 mM Tris-HCl  
192 mM Glycine 
20 % (v/v) MeOH 
0.01% SDS 
Western blot 
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MEDIA 
All media used in this work are shown in the table. All media were autoclaved or sterile 
filtered before use.  
Table 4 Bacterial and mammalian media 
NAME INGREDIENTS 
Cell Culture Medium (A10, A7r5) 
DMEM (Gibco)10 % FBS (Sigma-Aldrich) 
1% Penicillin (100 U) Streptomycin (100 µg) 
(Pen/Strep, Invitrogen) 
Cell Culture Medium (HEK293) 
DMEM/F12 1:1 (Gibco) 
10 % FBS (Sigma-Aldrich) 
1% Penicillin (100 U) Streptomycin (100 µg) 
(Pen/Strep, Invitrogen) 
Cell Culture Medium (raVSMCs) 
DMEM/F12 1:1 (Gibco) 
10 % FBS (Sigma-Aldrich) 
1% Penicillin (100 U) Streptomycin (100 µg) 
(Pen/Strep, Invitrogen) 
LB media for 1 L 25 g LB-dry powder, ddH20 to 1 L, pH 7.0 
LB agar plates 
15 g/l bacto agar 
50 mg/l ampicillin or 35 mg/l Kanamaycin 
 
INSTRUMENTs 
Table 5 list of used instruments during this work. 
INSTRUMENT PROVIDER 
10, 20, 100, 200, 1000 µl, pipette Eppendorf 
Autoclave Varioklav 
Avanti Centrifuge G-52 I Beckman Coulter 
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Cell Culture Hood Airclean-Telstar 
Centrifuge 5412 (refrigerated) Eppendorf 
Centrifuge Micro 200 Hettich 
Confocal laser microscope Olympus 
Electrophoresis Chamber  Hoefer 
FACS Applied Bioscience 
High Voltage Power Pack P30 Biometra 
High-speed centrifuge (refrigerated) RC-5C plus Sorvall 
Incubator shaker innova 4000 New Runswick Scientific 
Incubator shaker innova 4300 New Runswick Scientific 
Incubator Heraeus 
Infrared Imaging System Odyssey LI-COR 
Inverted Microscope Leica 
Nanodrop Spectrophotometer 1000 PeqLab 
Operating Scissor World Precision Instruments 
PCR Thrmocycler 5436 MJ Research 
Real-Time PCR System (One-Step) Life Technology 
Thermomixer 5436 Eppendorf 
Ultra-centrifuge rotor (TLA-55) Beckman 
Ultrasound water bath (2200) Branson 
Vortex Mixer (MS525-20) Heidolph (Reax) 
Western Blot Chamber Bio-Rad 
Water Bath Grant 
Water Bath Shel-Lab 
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BACTERIA STRAINS AND MAMMALIAN CELLs 
Table 6 List of used bacterial for cloning and sub-cloning process.  
 
VECTORS AND PLASMIDs 
All vectors used in this work are listed in the table 7. All Fluorescent vectors used for 
SYNPO2, 14-3-3γ, 14-3-3β, Importinα (Table 7) were taken from the vector bank of the 
group of Prof. Dr. Papadopoulos. Splice vectors (YFP-ΔC, YFP-ΔN) used for BIFC assay were 
a kind gift from Prof. Dr. Beam, University of Colorado, USA. All Plasmids used to study 
SYNPO2 were prepared by me. Table 7 List of vectors and plasmids used in this work 
NAME GENE ANTIBIOTIC RES. 
pECFP-N1 14-3-3γ Kanamycin 
pECFP-C1 14-3-3γ Kanamycin 
pECFP-N1 14-3-3β Kanamycin 
pECFP-C1 14-3-3β Kanamycin 
pECFP-N1 Importinα Kanamycin 
pECFP-C1 Importinα Kanamycin 
pEYFP-N1 SYNPO2 Kanamycin 
pEYFP-C1 SYNPO2 Kanamycin 
pCDNA1-YFP-ΔC (YFP-1-158) 14-3-3γ Ampicillin 
pCDNA1-YFP-ΔN (YFP-159-238) 14-3-3γ Ampicillin 
pCDNA1-YFP-ΔC (YFP-1-158) 14-3-3β Ampicillin 
NAME SOURCE 
BL21 Rosetta (DE3) Institute of physiology 
E. Coli Xl-1 blue Institute of physiology 
A10 Institute of physiology 
A7r5 Institute of physiology 
HEK293 Institute of physiology 
raVSMC Primary isolated 
P a g e  | 43 Materials and Methods 
pCDNA1-YFP-ΔN (YFP-159-238) 14-3-3β Ampicillin 
pCDNA1-YFP-ΔC (YFP-1-158) SYNPO2 Ampicillin 
pCDNA1-YFP-ΔN (YFP-159-238) SYNPO2 Ampicillin 
pCDNA1-YFP-ΔC (YFP-1-158) Importinα Ampicillin 
pCDNA1-YFP-ΔN (YFP-159-238) Importinα Ampicillin 
pcDNA3-mRuby2 14-3-3γ Ampicillin 
pcDNA3-mRuby2 14-3-3β Ampicillin 
pGEX4T-1 14-3-3γ Ampicillin 
 
PRIMERs 
All primers were designed by using NCBI and Snap-Gene program and NTI. The primers 
were purchased from both MWG-Biotech and Invitrogen. 
 
Table 8 List of primers used in this work 
PRIMER SEQUENCES DIG. SITE Add. 
INFORMATION 
GAGAGAGGATCCATGGTGGACCGCGAGCAACTAGTGC BamHI 
14-3-3γ into 
pGEX4T-1 
GAGAGAGAATTCTTAGTTGTTGCCTTCGCCGCCGTC EcoRI 
14-3-3γ into 
pGEX4T-1 
GAGAGAAGATCTATGGTGGACCGCGAGCAACTAG BglII 
14-3-3γ into 
pECFP-C1 
GAGAGAGGATCCTTAGTTGTTGCCTTCGCCGC BamHI 
14-3-3γ into 
pECFP-C1 
GAGAGAAGATCTATGGTGGACCGCGAGCAAC BglII 
14-3-3γ into 
pECFP-N1 
GAGAGAGGATCCcgGTTGTTGCCTTCGCCGCC BamHI 
14-3-3γ into 
pECFP-N1 
GAGAGACTCGAGATGTTTAAGAAGCGGAGG BglII SYNPO2 into 
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pEYFP-C1 
GAGAGAGGATCCTCACTCTTCCACAACTGAAGG BamHI 
SYNPO2 into 
pEYFP-C1 
GAGAGAAGATCTATGTTTAAGAAGCGGAGGCG BglII 
SYNPO2 into 
pEYFP-N1 
GAGAGAGGATCCTCTTCCACAACTGAAGG BamHI 
SYNPO2 into 
pEYFP-N1 
AGAGAGAGGCGGCCGCAATGGTGGACCGCGAGCAACT
AGTGC 
NotI 
14-3-3γ into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
AGAGAGAGTCTAGATTAGTTGTTGCCTTCGCCGCCGTC XbaI 
14-3-3γ into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
GAGAGAGCGGCCGCAATGACCATGGACAAAAGTGAGC NotI 
14-3-3β into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
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GAGAGATCTAGATTAGTTCTCTCCCTCTCCAGCATC XbaI 
14-3-3β into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
 
GAGAGAGCGGCCGCAATGTCCACCAATGAGAATGC NotI 
Importinα into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
GAGAGATCTAGATTAGAAGTTAAAGGTCCCGGG XbaI 
Importinα into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
GAGAGAGCGGCCGCAATGTTTAAGAAGCGGAGGCGG NotI 
SYNPO2 into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
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GAGAGATCTAGATCACTCTTCCACAACTGAAGGTTTCC XbaI 
SYNPO2 into 
pCDNA1-YFP-
ΔC (YFP-1-158) 
and 
pCDNA1-YFP-
ΔC (YFP-158-
238) 
AGAGAGAGGCGGCCGCCACCATGGTGGACCGCGAGCA
ACTAGTGC 
NotI 
14-3-3γ into 
pcDNA3-
mRuby2 
GAGAGAGGATCCCGGTTGTTGCCTTCGCCGCC BamHI 
14-3-3γ into 
pcDNA3-
mRuby2 
GAGAGAGGATCCCGGTTCTCTCCCTCTCCAGCATC BamHI 
14-3-3β into 
pcDNA3-
mRuby2 
GAGAGAGCGGCCGCAATGACCATGGACAAAAGTGAGC NotI 
14-3-3β into 
pcDNA3-
mRuby2 
Quantitative Real-Time PCR Analysis 
CCATGGAGAAGGCTGGGG 
GAPDH 
CAAAGTTGTCATGGATGACC 
AGCCATGTACGTAGCCATCC 
β-actin 
CTCTCAGCTGTGGTGGTGAA 
CACCTATCCTCAGCCTCAGC 
Sm22 
TTCAAAGGACATTGGCTTCC 
CACCAGAAACCCAAGAGGAA 
CalD1 
CATCTTTTTCCGATGGGCTA  
ACCGCTTCGCCAACTAC Vimentin 
P a g e  | 47 Materials and Methods 
GTTGTCCCTCTCCACCTC 
CCGCTGTCTGGTCCAGAA 
Smoothelin 
GGCTTTTTGCCCATGATCA 
TTCTTCCTGGCGAGTCATCT 14-3-3 Beta 
CTGCATGGGTAGCATTGAGA  
GCCATGAAGAACGTGACAGA 14-3-3 Gamma 
TCTTCTTCTCGTTGCCATCC  
GATCGGGAGGATCTGGTGTA 14-3-3 Epsilon 
GCTCTTCTGGCTCCAATCAC  
AAACGTTGTAGGAGCCCGTA 14-3-3Zeta 
AGACTTTGCTTTCTGGCTGC  
TTACTACCGCTACCTGGCAG 14-3-3eta 
TCATCGAAGGCTTGTTTGGC  
TAGAGACCGAGCTCAGAGGT 14-3-3 Sigma 
CGATGATGCGCTTCTTGTCA  
AAGACCGAGCTGATCCAGAA 14-3-3 Tetha 
(tau) TGTCCGAGGTATCGGTCTTC 
 
ANTIBODIEs 
Table 9 List of all used antibodies in this work. 
NAME APPLICATION  SUPPLIER DILUTION HOST  
anti SYNPO2 WB, IF Prof. Chalovich 
1:100000, 
1:5000 
Rabbit 
anti CD90  FACS Miltenyi Biotec 1:100 Rabbit 
anti 
Caldesmon 
WB, IF Prof. Pfitzer 1:1000, 1:1000 Rabbit 
anti ß-actin WB, Sigma 1:500 Mouse 
anti α-SMA WB, IF Sigma 1:1000, 1:1000 Mouse 
P a g e  | 48 Materials and Methods 
anti GAPDH WB Sigma 1:25000 Rabbit 
anti Lamin B1 WB Prof. Noegel 1:4000 Rabbit 
anti γTubulin WB Prof. Noegel 1:100 Rabbit 
anti GFP WB Cell signalling 1:1000 Rabbit 
anti GFP WB Prof. Noegel 1:20 Mouse 
anti smMHC WB, IF Sigma-Aldrich 1:500 Rabbit 
anti Rabbit 
Dylight 800 
WB 
Thermo 
1:10000 
Goat or 
Monkey 
anti Rabbit 
Dylight 680 
WB 
Thermo 
1:10000 
Goat or 
Monkey 
anti Mouse 
Dylight 800 
WB 
Thermo 
1:10000 
Goat or 
Monkey 
anti Mouse 
Dylight 680 
WB 
Thermo 
1:10000 
Goat or 
Monkey 
Alexa Fluor® 
488 anti-
Rabbit IgG 
IF Invitrogen 1:1000 Goat 
Alexa Fluor® 
555 anti-
Rabbit IgG 
IF Invitrogen 1:1000 Goat 
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2.2 Methods 
2.2.1 Molecular biology methods 
 
2.2.1.1 Total RNA isolation and cDNA synthesis 
Cells were trypsinized or were mechanically harvested and total RNA or/and DNA was 
isolated using the Maxwell® 16 LEV simply RNA tissue kit and/or the Maxwell® 16 LEV 
Blood DNA kit (Promega, Madison, WI) according to the manufacturer’s instructions or by 
RNeasy Mini Kit (Qiagen).  
 
2.2.1.1.1 Total RNA isolation by MAXWELL machine 
 Harvest the cells from a 10 cm cell culture plate at 80% confluent using 0.5% 
trypsin.  
 Spin the cells at 1500 rpm using a table centrifuge. 
 Remove the medium and wash the cells one time with cold PBS and spin one more 
time. 
 Homogenize the cells in 200 µl of buffer A (1-thioglycerol/homogenization 
solution = 1:1) by pipette. 
 Add 200 µl buffer B (Lysis buffer) into the mixture shortly before total RNA 
isolation. 
 Place the RNA isolation cartridge on machine plate and add 5 µl of the DNase into 
the tube four. 
 Add cell mixture to the tube 1 and mix briefly.  
 Place a 500 µl tube in the elution place at cartridge and add 50 µl of elution buffer 
into the tube. 
  Place the isolation plate in the machine and start appropriate program. 
 Determine RNA concentration with Nanodrop 1000. 
 Use RNA for cDNA synthesis.  
 Freshly isolated RNA, must be used directly after isolation for further experiment 
or store at -80°C for long time used. 
P a g e  | 50 Materials and Methods 
2.2.1.1.2 cDNA synthesis 
The single strand cDNAs were synthesized from isolated total RNA with the Quantitect® 
Reverse Transcriptase Kit (Qiagen, Germany) using random primers following the 
manufacturer’s protocol. In this work typically 1 μg of total RNA per 20 μl cDNA reaction 
mixture was used.  
The reaction mixtures were prepared as follows: 
1) Genomic DNA elimination reaction:  
2 µl of gDNA Wipeout Buffer (7X) 
1 µg total RNA (variable volume) 
RNase-free water (variable) up to 14 µl 
Incubation at 42°C for 2 min 
2) Reverse-Transcription reaction: 
1 µl Reverse transcriptase  
4 µl reverse transcriptase buffer (5X) 
1µl primer Mix 
• Mix the reaction mixture 1 and 2 together and incubate at 42°C for 15 min  
• Incubate the RT-reaction mixture at 95°C for 3 min to inactive the reaction 
2.2.1.2 Preparative PCR 
The PCR reaction mixtures were generally mixed as shown in table 10 in a 0.2 ml PCR 
tube. The PCR reaction was run in a thermo-cycler (PCT-100® Thermal Cycler, MJ 
Research) according to the listed program in table 11.   
 
Table 10 General PCR Mixture used in this work 
 Material Volume (µl) Concentration 
1 PCR Buffer (5X) 10 1X 
2 Primers (10 pmol/ µl) 5 (each primer) 0.5 µM 
3 Template 0.1-05 µg  
4 dNTPs (each 2 mM) 5 200 µM 
5 Polymerase* 0.5 1 unit 
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6 Water (DEPC) Up to 50  
7 Total 50  
*Phusion® High-Fidelity DNA Polymerase was used as standard polymerase in preparative PCR. 
 
Table 11 PCR Programs used in this work 
 Cycle Temperature Time 
1 1X 98°C 2 min 
2 30X 98°C 10 sec 
3 Depending on used primer 20-30 sec 
4 72°C 30 sec for 1 kb 
5 1X 72°C 5 min 
6 1X 4°C  
 
2.2.1.2.1 Purification of PCR products 
PCR products were purified depending on the size of the DNA fragments with different 
TAE agarose-gel concentration as listed in the table 12.  
 
Table 12 Concentration of TAE agarose for DNA purification (taken from molecular cloning: a laboratory 
manual, Michael R. Green and Joseph Sambrook, 2nd Ed) 
Amount of agarose (% [w/v]) Efficient of separation (KB) 
0.3 5-60 
0.6 1-20 
0.7 0.8-10 
0.9 0.5-7 
1.2 0.4-6 
1.5 0.2-3 
2.0 0.1-2 
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Using protocol according to manufacturer’s protocol: 
1. Weight and dissolve desired amount of agarose in 1X TAE buffer by heating 
2. Add 5 µl EtBr to the gels 
3. Mix PCR products with appropriate amount of 10X DNA loading buffer and load on 
TAE agarose-gel. Use 1kb marker as standard 
4. Run the gel at 60 Volt in 1X TAE 
5. Excise desired band and extract the DNA using a gel extraction kit from Qiagen 
according to the manufacture protocol.  
2.2.1.2.2 Sub-Cloning 
Digestion of PCR products and vectors 
Both PCR products and vectors were digested by the same appropriate restriction 
enzymes as listed in table 6.7. Preparation of digestion mixtures and used time are listed 
in the table 13 according to the manufacturer’s instructions. 
 
Table 13 Digestion mixture and using times 
 Components Volumes (µl) Volumes (µl) 
1 10X Buffer (NEB or fermentas) 5 10 
2 Vector (0.2 µg/µl) or PCR product (1 µg/µl) 10 55 
3 Enzyme** 3 5 
4 Enzyme** 3 5 
5 Water 29 25 
6 Total 50* 100 
* Digested vectors were treated by Alkaline Phosphatase, Calf Intestinal (CIP) for 1 h at 37°C (NEB). 
** 1 unit of enzyme can digest 1 µg DNA. 
  
Ligation of PCR products into the vectors  
Ligation was performed using a quick ligation Kit (New England Biolabs
® Inc. Germany) 
according to the manufacture’s protocol. After purification of digested products by using 
a PCR purification kit or by TAE agarose gel, products and appropriate vectors were 
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generally mixed together in a ratio of 8:1 as listed in table 14. The ligation reactions were 
incubated for 5 to 10 min at room temperature and deactivated as described in 
manufacture’s protocols. 
 
Table 14 Used ligation reaction mixture in this work 
 Materials Volume (µl) 
1 Ligation buffer 10 
2 T4-Ligase 1 
3 Vector  1 
4 Insert  8 
5 Total  20 
 
2.2.1.2.3 Transformation 
To get a large amount of plasmids, desired ligation reactions were transformed under 
heat stress into chemical competent E coli Xl-1 blue strain as described. 
1. Add 5 µl of ligation reaction mixture to 100 µl of competent E.coli Xl-1 blue and 
incubate the mixture on ice for 30 min. 
2. Incubate the cells at 42°C for 45 Sec and briefly cool on ice. 
3. Add 900 µL LB medium to the cells. 
4. Incubate the cells on a shaker at 37°C for 1 h. 
5. Spin the cells at 3000 rpm for 30 Sec. 
6. Spread 100 µl of cells on LB-Agar plate with appropriate antibodies. 
7. Incubate the plate at 37°C, overnight. 
2.2.1.2.4 Colony PCR 
On the following day, after transformation and plating the cells on LB-agar with 
appropriate antibiotic colonies were picked and analyized by colony-PCR with appropriate 
primers. 
1. Select and pick a single bacteria colony using a pipette tip. 
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2. Pick the tip in a PCR reaction tube and inoculate 3 ml of LB medium with 
appropriate antibody with the same pipette tip. 
3. Incubate the LB medium at 37°C, overnight, 200 rpm. 
4. Add PCR reaction mixture to the PCR reaction tube and run a PCR Table 15. 
5. Analyze the PCR products by 1X TAE agarose-gel.  
 
Table 15 Colony PCR reaction mixture 
 Components Volume (µl) Concentration 
1 Buffer (10x) 2.5 1x 
2 Primer (10 pmol) 1.75 500 nM 
3 dNTPs (each 2 mM) 2.5 200 µM 
4 Sample DNA Bacterial colony  
5 MgCl2 1.5  
6 Taq DNA polymerase 0.25 1 unit 
7 H2O 14.75  
8 Total 25  
 
2.2.1.2.5 Preparation of plasmid DNA 
MINI PREP 
All plasmids prepared in this work were purified using a Qiagen Mini-Prep kit according to 
the manufacture’s protocol.  
1. The day after transformation, one single colony was picked and dissolved to 3 ml 
of LB-Medium containing the antibiotic.  
2. The bacteria were grown at 37°C under shaking for over night. 
3. The bacteria were harvested at 13 000 rpm by using a table centrifuge. 
4. 250 µl of buffer P1 was added to the cell pellet and mixed by a vortex. 
5. 250 µl of buffer P2 was added and mixed gently by inverting until the solution 
became clear. 
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6. 350 µl of buffer N3 was added to the bacterial lysate and mixed by inverting to 
precipitate proteins, lipids and chromosomal DNA. 
7. The mixture was centrifuged at 13 000 rpm for 10 min. 
8. The resulted supernatant was added on a spin column and centrifuged at 13 000 
rpm for 1 min. 
9. The bound plasmid on the column was washed one time with buffer HB (500 µl) 
and one more time with 750 µl of wash buffer containing ethanol (13 000 rpm, 1 
min). 
10. Finally the column was placed in a 1.5 ml tube and the plasmid was eluted by 50 µl 
elution buffer or water (13 000 rpm, 1 min). 
 
2.2.1.2.6 Test digest screening 
To prove the accuracy of ligation process, generated plasmids were digested by the 
appropriate restriction enzymes. After concentration estimation, 1 µg of Plasmid was 
digested by the appropriate restriction enzymes and analyzed by using a 1X TAE agarose 
gel.  
 
2.2.1.2.7 DNA sequencing 
To check accuracy of ligated DNA into the vectors and analyze the sub-cloning, 
sequencing of yielded plasmids was performed by MWG Biotech according to the 
manufacture’s protocols. 
Preparation of Plasmid for sequencing:  
 50-100 ng of Plasmid in 15 µl total volume in a 1.5 ml save-lock Eppendorf tube.   
 
2.2.1.3 Quantitative polymerase chain reaction (qRT-PCR) 
For analysis of gene expression levels, the RNA has to be transcribed into cDNA using a 
reverse transcriptase. In this work we used a tow step reaction. The RNA is first reverse 
transcribed into cDNA as described before with random oligomers (see 2.2.1.1.2). Finally, 
an aliquot of the reverse-transcription reaction is used for the real-time PCR. The gene 
specific primers were designed by Snap-Gene software 2.2.2 or Vector NTI Advance 10 
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and ordered by Invitrogen, science-technology or MWG Biotech (listed in Table 8). The 
Real-Time PCR reaction mixtures were generally mixed as shown in table 16 in a 0.1 ml 
MicroAmp Fast 96-well Reaction Plate (life Technologies, 4346907). The Real-time PCR 
was carried out with a GoTaq® qPCR Master Mix (Promega, Madison, WI) and was run in a 
thermo-cycler (StepOnePlus™ real-time PCR System, life Technologies) according to the 
listed program in table 17. Data analysis was achieved by StepOne Software v2.3.   
Table 16 General Real-Time PCR Mixture in This Work 
 Materials Volume µl Concentration 
1 GoTaq® qPCR Master Mix 2X 10 1X 
2 Primers (10 pmol/ µl) 2 each  1 µM 
3 Nuclease-Free Water 2  
4 cDNA (RNA 100 ng/20 µl) 4 20 ng 
5 Total 20  
 
 
Table 17 Real-Time PCR Program used in This Work 
 Step Cycle Program  
1 Activation 1 95°C, 10 min 
2 Denaturation  40 95°C, 15 Sec 
Annealing/Extension 60°C, 1 min 
3 Melt Curve 1 95°C, 15 Sec 
60°C, 1 min 
95°C, 15 Sec 
 
2.2.1.3.1 Analysis of qRT-PCR data 
In this work, we calculated gene expression levels of our genes of interest by determining 
the ratio between the amount of a target gene and an endogenous reference gene that is 
equally expressed in all samples. Resulting raw data from Real-time PCR were analyzed by 
a free StepOne software V2.3 (Life Technologies). ROX dye was used as a passive 
reference for all analysis. The samples were run in triplicates, and the experiments were 
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repeated at least three times. The mRNA levels were normalized against the endogenous 
control (GAPDH) levels and calculated using the delta cycle threshold (Ct) method.  
 
2.2.2 Cell biology methods 
2.2.2.1 Isolation of vascular smooth muscle cells from rat aorta 
rVSMCs were prepared by an enzymatic digestion published by Golovina et al. 2006131 
(Fig. 7).  
I. After anesthetizing, the aorta and vein were removed from the 6-8 weeks old rat 
under sterile conditions and transferred quickly in PBS, pH 7.4 (Gibco) that contains 
fungicide (Gibco, 0.2 mg/ml), and Pen/Strep (Gibco, 100 U/ml and 100 µg/ml) and 
stored for 15 min.  
II. Transfer tissues after 15 min in a sterile 6 cm cell plate with 1-2 ml HBSS (Gibco, with 
Ca2+ and Mg2+) buffer with fungicide and antibiotics.  
III. Remove adherent fat and connective tissue from the aorta under a dissection 
microscope. 
IV. In order to avoid contamination, the same process was performed when removing the 
vein. 
V. Remove blood from the aorta and vein by injecting HBSS.  
VI. The further steps were performed under a laminar flow hood.  
VII. Transfer the tissues to a 3.5 cm plate containing the first enzyme solution (2 mg 
collagenase type 2 (Worthingen, #LS004194) in 1 ml HBSS (Gibco, without CaCl2 and 
MgCl2)) and incubate for 45-60 min at 37°C and 5% CO2.  
VIII. Remove carefully the partially digested tissues from the enzyme solution and wash 
once in HBSS (with Ca2+ and Mg2+). 
IX. Remove under a dissecting microscope, adventitia from the aorta 
X. Cut the aorta and vein tissues, that contain smooth muscle cells and endothelial, 
longitudinally with fine scissors. 
XI. Remove carefully the endothelial layer by using a fine scraper.   
XII. Transfer and incubate the aorta and vein in pre-warmed medium (DMEM, 10% FBS, 
Pen/Strep, 100 U/ml and 100 µg/ml) and incubate overnight at 37°C and 5% CO2. 
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XIII. Remove the medium and wash the tissues twice by HBSS (without CaCl2 and MgCl2). 
XIV. Cut partially digested tissues with fine scissors in 1-2 mm pieces in the enzyme 
solution II (Collagenase type 2 and type 1 (2 mg/ml each, Worthingen) in HBSS buffer 
without CaCl2 and MgCl2)   
XV. Incubate the mixture for 4 hours at 37°C and 5% CO2. 
XVI. Stop the enzymatic reaction by adding 4 ml of culture medium and re-suspend the 
cells in DMEM medium. 
XVII. Spin the cells at 500 xg for 5 min. 
XVIII. After removing the supernatant, re-suspend the cells in 1 ml culture medium DMEM 
containing Pen/Strep (100 U/ml and 100 µg/ml). 
XIX. Use media without FBS at this step to avoid the growth of epithelial cells and 
fibroblasts. 
XX. Count the cells using trypan blue and determine the number of dead cells to compare 
the viability of cells at different days and in different cell types. 
XXI. For further characterization by immunofluorescence staining, plate 2 x 104 cells on 
coverslips in a 24-well culture plate. Alternatively plate cells in a 10 cm culture dish for 
biochemical experiments. 
XXII. Change 80% of culture medium every 2 or 3 days.  
XXIII. In order to check the viability and growth ratio, cells were digested with 0.5% Trypsin-
EDTA every second or third day. 
 
 
 
 
 
 
Fig. 7 Schematic illustration: Isolation of vascular smooth muscle cell from rat aorta using enzymatic 
method. 
 
4 h 
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2.2.2.2 Cell culture and treatments 
VSMCS 
Rat vascular smooth muscle cells (rVSMCs) were seeded at a density of 2.5 X 104 cells/cm2 
on coverslips, pre-coated with 0.1% gelatin, and left grown in DMEM supplemented with 
10% FBS and 100 U/ml Pen and 100 µg/ml Strep in a humidified atmosphere at 37°C, 5% 
CO2. When the cells were 70% confluent, medium was replaced by serum free medium 
and cells were incubated for further 2 h prior to each experiment. Finally, cells were 
treated with different effectors, DMSO as vehicle control or not treated at all. The used 
concentrations of inhibitors and activators in this work and incubation times are listed in 
table 18. In case of heat shock studies and activation by PKA and CaMKII, experiments 
were performed with freshly isolated cells, where SYNPO2 is localized in the cell 
cytoplasm, while inhibitor studies were executed with cells from passage 2 to 4, where 
SYNPO2 accumulated in the cell nucleus.  
 
Table 18 Used incubation times and treatment conditions for this study 
Component Concentration Time Inhibited Activated Company 
urocortin 100 nM 1 h  cAMP signaling Sigma-Aldrich 
Sp-5.6-DCl-
cBIMPS 
10 µM 1 h  PKA BioLog 
forskolin 10, and 20 µM 1 h  cAMP signaling 
ICN 
Biomedicals 
KN93 10 µM 1 h CaMK-II  Calbiochem 
H89 10 µM 1 h PKA  Sigma-Aldrich 
Rp-8-PIP-
cAMPS 
100 µM 1 h PKA  BioLog 
Okadic acid 100 nM 1 h 
PP2A and 
PP1 
 Sigma-Aldrich 
Y-27632 10 µM 1 h ROCK  Tocris 
IBMX 10, 20 µM 1 h PDEs  Sigma-Aldrich 
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In order to analyze whether the phenotype switch of VSMCs affects subcellular 
localization of SYNPO2, VSMCs from day 1 (contractile phenotype) and passage 2 
(synthetic phenotype) at 25 x 103 cells/cm2 were seeded on coverslips for 
immunofluorescence studies or let grown in a 10 cm cell culture plate for biochemical 
studies. VSMCs at passage 3 were seeded on polyacrylamide matrices pre-coated with 
collagen type 1 (Upstate) or laminin (Sigma Aldrich) as extracellular matrix proteins, 
respectively, and let grown for 48 h prior to each experiment. Cells were grown in DMEM 
medium (high glucose), Life Technologies, supplemented with 100 U/ml Pen and 100 
µg/ml Strep and 10% FBS in a humidified atmosphere at 37°C and 5% CO2. Cells on pre-
coated polyacrylamide matrices (pre-coated by collagen I, and laminin) were used to 
study the effect of cytochalasin D and Jasplankloide on SYNPO2 distribution in the cells. 
Medium was replaced with serum free medium 2 h before each experiment. At least 150 
cells (3 X 50) from four independent experiments were used for statistical analysis of 
subcellular localization of SYNPO2 in VSMCs.  
HEK293 Cells 
In order to investigate the subcellular localization and the interaction studies between 
SYNPO2, 14-3-3γ/β, and importinα, HEK293 cells were seeded on ECL (Entactin, 
CollagenIV, Laminin, MILLIPORE, 08-110) pre-coated coverslips placed in 6 wells cell 
culture plate, and let grown in DMEM supplemented with 10% FBS, 100 U/ml Pen, 100 
µg/ml Strep at 37°C in a humidified atmosphere of 5% CO2. Cell were transiently co-
transfected with 300 ng of constructs by the calcium phosphate method: 
 
1. Prepare 2 M CaCl2 solution in water, filter sterile and keep at room temperature.  
2. Prepare the 2x HBS buffer:  
50 mM HEPES  
280 mM NaCl  
1.5 mM Na2HPO4  
Adjust pH to 7.0 using HCl. Filter sterilize. The solution can be frozen/thaw once for 
future use.  
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3. Incubate HEK-293 cells in DMEM medium with 10% FBS, 100 U/ml Pen, 100 µg/ml 
Strep at 37°C, 5% CO2.  
4. 24 hours before transfection, trypsinized and reseed log-phase cells into 35 mm tissue 
culture dishes. Seeding density should be that the cells reach 60~70 % confluence for 
transfection.  
5. 3 hours before transfection, replenish cells with fresh medium.  
6. For each DNA transfection, prepare following mixtures in two separate tubes:  
Solution-A: 100 μl 2x HBS  
Solution-B: 0.3-0.5 µg DNA + 12.2 μl of 2 M CaCl2 and ddH2O to bring volume up to 
100 μl, pipet gently to mix.  
7. Add the Solution-B slowly (drop-wise) into Solution-A while mixing Solution-A.  
8. After mixing the two solutions, incubate at room temperature for 20-30 minutes. The 
solution will become opaque while precipitates form.  
9. Gently tap the mixture. Add the mixture directly to cells by dripping slowly and evenly 
into medium (a good way is to let tip touch medium surface).  
10. Gently tilt the plate back and forth a couple of times to allow evenly distribution of 
added precipitate on the cell surface.  
11. Incubate the cells at 37oC with 5% CO2 for 24 hours, replenish medium.  
 
2.2.2.3 Immunofluorescence staining 
Cell on coverslips 
To visualize the subcellular localization and translocation of SYNPO2, seeded VSMCs were 
serum starved 2 h before each experiment. After treatment (see 2.2.2.2) cells were briefly 
fixed with 4% PFA in 1X PBS (10 mM sodium phosphate, 2.68 mM KCl, 140 mM NaCl, pH 
7.4) for 15 minutes and permeabilized with 0.4% triton X-100 diluted in blocking buffer 
(5% BSA diluted in PBS) for 15 min at room temperature (RT). Cells were then washed 
three times with PBS, 5 min each, and blocked with blocking buffer for 45 min at RT. The 
cells were incubated with primary antibodies diluted in blocking buffer for 1 h at RT. 
Excessive antibodies were washed off with PBS and cells were incubated with secondary 
antibodies for one further hour followed by 3 washes with PBS. To visualize the nucleus 
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and the actin cytoskeleton, cells were incubated with Hoechst 33342 and Alexa-555 
conjugated phalloidin (Life Technologies, Carlsbad, CA) diluted in blocking buffer for 1 h. 
Finally, cells were fixed on microscopic slides with PolyGlass coverslip mounting medium 
(Polysciences, Warrington, PA). 
Cells on coated polyacrylamide matrices 
Cells on pre-coated (Collagen I, Laminin) polyacrylamide matrices were fixed with 4% PFA 
for 30 min at room temperature. After permeabilization with triton X-100 for 15 minutes 
the cells were blocked for 1 h with blocking buffer. Incubation with primary and 
secondary antibodies as well as the staining of the actin cytoskeleton with Fluorescent 
labeled phalloidin and staining of the nucleus with Hoechst 33342 were performed as 
described above. Images were recorded with an Olympus Fluoview FV1000 confocal laser-
scanning microscope using the appropriate filters. 
 
2.2.2.4 Confocal microscopy  
In this work an Olympus laser confocal microscopy was used to capture the images and to 
analyze localization, distribution and interaction of different immunostained and 
Fluorescent-fused proteins. In confocal images, Alexa-488 immunostained proteins were 
excited at 488 nm and observed from 505 to 525 nm. Alexa-555-Phalloidin (actin 
cytoskeleton) was excited at 515 nm and observed from 525 to 565 nm. The nucleus of 
cells was stained using Hoechst 33342 and excited at 350 nm, and the images were 
captured from 460-490 nm. Moreover, CFP fused proteins were detected at 458 nm and 
YFP fused proteins were detected at 465-495 nm. The images were 512 * 512 pixels. The 
captured images were analyzed either by a commercially available program FV-10-ASW 
2.0 Viewer or by using NIH-software ImageJ. For statistical analysis at least three 
independent experiments were performed where each time 150 cells were counted. The 
results were analyzed by Student’s t-test.  
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2.2.3 Biochemical and analytical methods 
2.2.3.1 Characterization of isolated VSMCs 
Although, previous studies have shown that the cell populations isolated by enzymatic 
methods are almost smooth muscle cells, a minor contamination found using these 
methods are fibroblasts. With regard to this fact, we tested the purity of our isolated 
VSMCs by FACS analysis and Western blot using specific antibodies directed against 
VSMCs, like anti αSMA, smMHC, and desmin or anti CD90 directed against fibroblast cells. 
 
2.2.3.2 Fluorescence activated cell sorting assay (FACS) 
FACS, also known as Flow cytometer, is a laser-based, biophysical technology by which 
cells are counted and analyzed in a stream of fluid passing by an electronic detection 
device. FACS analysis was achieved by an attune acoustic focusing cytometer (Applied 
Bioscience), AG Saric (Institute of Neurophysiology). Isolated cells were characterized by 
using a fibroblast specific antibody against Cluster differentiation 90 (CD90)132. CD90 also 
known as Thy-1 is a 25- to 37-kD heavily N-glycosylated surface protein that anchored to 
the cell membrane of fibroblasts via a glycosylphosphatidylinositol (GPI) and is expressed 
on mesenchymal stem cells and fibroblasts133, 134. In order to analyze and to estimate the 
fibroblast contamination, freshly isolated VSMCs and as positive control STO fibroblasts 
(Mouse embryonic fibroblast cell line) were incubated with anti-CD90-FITC (Miltenyi 
Biotec, 1:100) diluted in 50 µl PBS and 1% FBS or FCS for 1 h at 4°C. Untreated STO cells 
were used as a negative control. A mouse IgG-FITC labeled antibody was used as 
secondary antibody to exclude unspecific cross reactivity. Cells were washed three times 
with washing buffer (PBS, 1% FBS or FCS), each 5 min. Finally, cells were suspended in 500 
µl PBS containing 1% FBS or FCS. 10,000 events per sample were acquired at BL1 cannel 
for green fluorescence on flow cytometer and the data were analyzed with Cell Quest Pro 
software (Beckton Dickinson).  
 
2.2.3.3 Subcellular fractionation 
Cytoplasmic and nuclear fractions were prepared according to two methods: Neumann et 
al. 2010135 and Thakar et al. 2013136, followed by Western blot analysis to quantify the 
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subcellular distribution of SYNPO2 in VSMCs. The methods are based on isolation of 
subcellular fractions using different buffers and centrifugal forces. 
For subcellular fractionation and the following Western blot analysis, cells were seeded at 
5 x 105 on 10 cm cell culture plates and grown to 80% confluence. Cells were mechanically 
harvested on ice in medium and centrifuged at 110 xg, 4°C for 5 min (Eppendorf 5417). 
According to Neumann et al. 2010 
The cells were briefly washed (4-5 Sec.) with hypotonic buffer (10 mM HEPES, pH 7.9, 1.5 
mM MgCl2, and 10 mM KCl containing protease inhibitor cocktail (PIC, Roche) and 1 mM 
PMSF) and directly centrifuged for 20 seconds at 110 xg, 4°C. The cell pellets were 
suspended in hypotonic buffer, incubated for 10 min on ice, and then completely 
disrupted by passing 10 times through a needle (26G x 2/4”). The cytoplasm was 
separated from the nuclear fraction by centrifugation (10 min, 110 xg, 4°C). The 
supernatant (cytoplasm) was stored on ice and the pellet, containing the nuclei, was 
washed 6 times with ice cold PBS containing 1 mM PMSF and PIC (Roche). The cytoplasm 
was clarified by centrifugation at 1500 xg for 20 minutes, and 4°C. Protein concentrations 
of the fractions were determined by the Bradford assay to ensure loading of equal 
protein amounts on the SDS-gels. The nuclear and cytoplasmic proteins were resolved on 
10% SDS gels transferred to nitrocellulose membrane and probed with the appropriate 
antibodies as described in the section 2.2.3.4. The purity of the isolated fractions was 
tested by specific antibodies against GAPDH (cytoplasmic protein), and Lamin 1B (nuclear 
membrane protein).  
 
According to Thakar et al. 2013 
Subcellular fractionation was performed according to the protocol of Thakar et al. 
(2013)136 with small modifications. After harvesting as described above, cells were briefly 
suspended in 400 µl buffer A (50 mM HEPES, pH 7.4, 150 mM NaCl, 1% triton X100, 1 mM 
PMSF and protease inhibitor cocktail (Roche)) and incubated on ice for 10 min. The 
mixtures were centrifuged for 10 min at 3000 xg, 4°C. The resulting supernatants 
represented the cytosolic fractions. The pellets were suspended in 400 µl buffer B (50 
mM HEPES, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 1 mM PMSF and PIC (Roche)), 
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incubated for 30 min on ice, and then centrifuged at 7000 xg for 10 min. The supernatants 
contained the membrane-bound organelles and were stored on ice. The remaining 
pellets, containing the nuclear proteins, were suspended in 400 µl buffer C (50 mM 
HEPES, pH 7.4, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1 mM PMSF and PIC 
(Roche)), incubated on ice for 1 h, and centrifuged at 7000 xg for 10 min. The resulting 
supernatants, containing the nuclear proteins were stored on ice. Protein concentrations 
of the fractions were determined by the Bradford assay as already described and 
subjected to gel-electrophoresis. 
  
2.2.3.4 SDS-PAGE and Western blot analysis 
Cells from cell culture plate 
For protein analysis, VSMCs that had reached 70% to 80% confluence were once washed 
with 1X PBS and incubated on ice. The cells were scratched on ice in 5 ml ice cold PBS and 
transferred in a 15 ml falcon tube. The cells were collected by centrifugation (110 xg, 5 
min at 4°C). Cell pellets were suspended in SDS sample buffer (8 M Urea, 100 mM Tris-
HCl, pH 6.8, 2% SDS (w/v), 0.2% bromophenol blue, 20 mM DTT, 1 mM PMSF, 1X PIC 
(Roche)) and incubated for 15 min at room temperature. Proteins were separated by gel 
electrophoresis on 10% SDS-polyacrilamid gels. Proteins were transferred to a 
nitrocellulose membrane using a Towbin buffer137 (25 mM Tris, 192 mM Glycin, 20% 
MeOH, 0.01% SDS) in a tank blot (110 volt, 70 min) on ice or in a cold room. Membranes 
were blocked for 30 minutes at room temperature with 5% nonfat milk in Tris-buffered 
saline (TBS (10 mM Tris, 150 mM NaCl, pH 7.5)) followed by incubation with primary 
antibodies (diluted in blocking buffer) for 2 h at room temperature or overnight at 4°C 
under rotation. After intensive washing with TBS (5 min each time) the membranes were 
incubated with IRDye 680CW or 800CW (Thermo) secondary antibodies (1:12,000 diluted 
in blocking buffer) at room temperature for 45 min followed by intensive washing with 1X 
TBS. The protein bands were visualized by densitometry scanning using the Odyssey 
Infrared Imaging System (LI-COR). 
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Cells on polyacrylamide matrices 
Isolation of cells from polyacrylamide matrices was achieved as described before138. Cells 
were seeded at a density of 2 x 105 cells/cm2 on polyacrylamide matrices 48 h prior to 
each experiment and let grown to a 70% confluence. After removing the cell culture 
medium, cells were harvested by 200 µl of RIPA buffer (25 mM Tris, pH 7.4, 137 mM NaCl, 
50 µM EDTA, 1% triton X100, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM PMSF, protease 
inhibitor cocktail (Roche)), incubated on ice for 20 min and centrifuged at 15,000 rpm for 
15 min, 4°C. 150 µl of the supernatants was mixed with 150 µl 2x SDS-Sample buffer (8 M 
Urea, 100 mM Tris-HCl, pH 6.8, 2% SDS (w/v), 0.2% bromophenol blue, 20 mM DTT, 1 mM 
PMSF, 1X PIC). The protein concentrations estimation and protein analysis were achieved 
as described above. 
HEK293 
In order to analyze the expression levels of fluorescent fused proteins in transfected 
HEK293 cells, protein extracts from cells were prepared in RIPA buffer and characterized 
by 1D SDS-PAGE and Western blot as described above.   
 
2.2.3.5 Estimation of F/G-Actin ratio 
In order to investigate whether the alteration of F/G-actin ratio connected with the 
subcellular distribution of SYNPO2 during phenotype switch, cells from passage 2 were 
plated on acrylamide matrices pre-coated with collagen I and laminin and let grown for 24 
h in a humidified atmosphere. On the following day, cells were treated with CCD, JASP or 
DMSO as control after 2 h serum starvation. F/G-actin ratio was measured using the F-
actin/G-actin in vivo assay kit. Treated VSMCs were homogenized in 100 µl LAS02 buffer 
(F-actin stabilization buffer, ATP, PIC) with a plastic pastel at RT, and centrifuged in a 
BioRad table-centrifuge at 350 xg for 5 min. Supernatants were collected and centrifuged 
at 100,000 xg (TLA-55) for 1 h at 37°C. The high-speed supernatant (G-Actin) was carefully 
removed, and 25 µl of 5X SDS-gel sample buffer was added. The high-speed pellet (F-
Actin) was resuspended in 100 µl of F-actin destabilization buffer and incubated for 1 h on 
ice. 25 µl of 5X SDS-gel sample buffer was added to the 100 µl F-Actin. Samples were 
stored at -20°C before running the SDS-PAGE and Western blotting. F/G-actin ratio 
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analysis occurred by using 4%-15% SDS-PAGE. Experiments were performed three times 
as duplicate. The results were analyzed by Student’s t-test using GraphPad Prism 4. 
 
2.2.4 Preparation of collagen I and laminin coated polyacrylamide matrices 
This experiment was performed by Dr. Carlos Omar Heras Bautista, Pfannkuche AG, 
Institute of Neurophysiology, Medical Faculty, University of Cologne. Polyacrylamide 
matrices were prepared as described before139. To prepare polyacrylamide matrices, 
polyacrylamide (PAA) solution was firstly mixed together as follow; 0.374 ml of 15% 
acrylamide (w/v), 0.150 ml of 0.3% N,N’-Methylenebisacrylamide (w/v), 0.010 ml of 1.5 M 
NaH2PO4 and 0.465 ml of distilled water. The solution was briefly vortexed and degassed 
for 5 min. 12.5 mg of 2,5-Dioxopyrrolidin-1-yl 6-acrylamidohexanoate (linker) was added 
to 1 ml of PAA solution, briefly sonicated, and warmed to 40°C for 3 min until it was 
dissolved. Polymerization of PAA matrices were started by the addition of 0.015 ml of 200 
mM potassium persulfate in distilled water (degassed) and 0.015 ml of TEMED (diluted 1 
to 10 in distilled water) to each 0.250 ml aliquot of PAA solution. To control the size of 
prepared matrices, PAA matrices were polymerized in a closed poly-Tetrafluoroethylen 
(Teflon) casts for 2 min. Resulting PAA matrices had 7 mm diameter and 1 mm thickness. 
Finally, PAA gels were washed twice with 200 mM Hepes pH 8.5 and 0.070 ml of Collagen 
I (40 µg/ml) or laminin 1 (20 µg/ml) in 200 mM Hepes pH 8.5 was added to each gel. 
Activated PAA gels were left at 4°C overnight. 
 
2.2.5 Stiffness measurement of polyacrylamide by atomic force microscopy 
Atomic Force Microscopy (AFM) was performed by Dr. Sabine Diluweit from the Institute 
of Complex Systems (ICS), research center Jülich. Measurements were done for sample, 
55 kPa, prepared according to the acrylamide/bis-acrylamide ratios used for each 
solution139. Each sample was polymerized to silanized microscope slides, with a thickness 
of 8 mm per sample. Measurements were performed in triplicates, and were performed 
twice, using solutions from different stocks, resulting in matrices prepared under various 
conditions. Each sample was measured several times on randomized locations. For each 
location, three cantilever displacements were performed and their resulting force-curve 
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was analyzed applying the extended Hertz model, obtaining the elastic modulus for the 
each analyzed sample 140-143. 
AFM experiments were performed using a commercial Atomic Force Microscope, 
Nanowizard (JPK, Berlin, Germany) in spectroscopy mode. The samples were measured in 
1X PBS. The cantilever was pressed onto several points of the sample with a velocity of 
1µm/s. Standard silicon tips were used with a nominal spring constant of k = 42 N/m 
(Atomic Force, Mannheim, Germany) and k = 2.8 N/m (Nanoandmore, Wetzlar, 
Germany). The tip shape was assumed as a cone with an opening angle of 20° respectively 
18°. The lower spring constant was determined using thermal fluctuations in air 144 and 
the value of the higher spring constant is given from the company. The sensitivity was 
determined under PBS on glass. 
 
2.2.6 Bimolecular fluorescence complementation assay (BIFC) 
Moreover, smooth muscle SYNPO2, 14-3-3γ/β, and importinα protein interaction analysis 
was achieved by using BIFC technique, an early reported technique. For BIFC 
measurements, HEK293 cells were seeded at 50% to 60% confluents either on ECL pre-
coated coverslips for the subcellular localization and the interaction studies or on a 12 
well cell culture plate for FACS analysis (2.2.7). On the following day, cells were 
transfected as described before with equal amounts (300 ng) of BIFC constructs using the 
calcium phosphate method. Table 19 summarizes the used BIFC-constructs, and their 
application in this chapter.  
 
Table 19 Used combinations of BIFC-constructs in this work. 
Construct 1 Construct 2 Application 
ΔN-YFP 
ΔC-YFP 
Control 1, whether ΔN-YFP 
interacts with other 
constructs and develops 
fluorescence 
ΔC-YFP-SYNPO2 
ΔC-YFP-14-3-3γ 
ΔC-YFP-14-3-3β 
ΔC-YFP-importinα 
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ΔC-YFP 
ΔN-YFP-SYNPO2 Control 2, whether ΔC-YFP 
interacts with other 
constructs and develops 
fluorescence 
ΔN-YFP-14-3-3γ 
ΔN-YFP-14-3-3β 
ΔN-YFP-importinα 
ΔN-YFP-SYNPO2 
ΔC-YFP-SYNPO2 
Dimerization study of 
SYNPO2 
ΔC-YFP-14-3-3γ 
Localization and interaction 
study 
ΔC-YFP-14-3-3β 
ΔC-YFP-importinα 
ΔC-YFP-SYNPO2 
ΔN-YFP-14-3-3γ 
Localization and interaction 
study 
ΔN-YFP-14-3-3β 
ΔN-YFP-importinα 
ΔN-YFP-14-3-3γ 
ΔC-YFP-14-3-3γ Dimerization study 
ΔC-YFP-14-3-3β Localization and interaction 
study ΔC-YFP-importinα 
ΔN-YFP-14-3-3β 
ΔC-YFP-14-3-3γ Dimerization study 
ΔC-YFP-14-3-3β Localization and interaction 
study ΔC-YFP-importinα 
ΔC-YFP-importinα ΔN-YFP-importinα Dimerization study  
 
2.2.7 FACS-BIFC based assay 
In order to quantify the BIFC-fluorescence development during protein-protein 
interaction, HEK293 cells were transfected at 70% confluent with different BIFC-
constructs using calcium phosphate methods and let grown for 24 h at a humidified 
atmosphere at 37°C, 5% CO2. For the preparation of single cell suspensions, cells were 
washed with 1X PBS, trypsinized, pelleted, suspended in PBS plus 1% FCS or FBS. Cell 
preparation and analysis were carried out consecutively for every sample, alternating the 
experimental and control condition (three times in duplicate). Per sample, 10,000 cells 
were analyzed on attune acoustic focusing cytometer (Applied Bioscience) at the Institute 
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of Neurophysiology (AG Saric) with excitation at 488 nm and registration with the 515-
545 nm filter. Cells were defined as BIFC positive if they fell in a rectangular gate that 
eliminates 99.9% of control condition cells (without constructs). 
2.2.8 Statistics 
All results are presented as means ± SEM from at least three independent experiments 
performed in triplicate. For comparison between specific groups of continuous variables, 
the Student's t-test was used. A p value < 0.05 was considered statistically significant. 
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3 Results 
 
3.1 Over 95% of the isolated cells were vascular smooth muscle cells 
Analysis of the isolated VMSCs by FACS assay using the fibroblast specific antibody anti-
CD90 showed that at least 95% of the isolated cells are VSMCs. As Fig. 8 shows, the 
mouse embryonic fibroblasts (STO fibroblast) used as a positive control gave in over 90% 
a positive signal when stained with the anti-CD90 antibody (Fig. 8A), while isolated SMCs 
demonstrated less than 3% positive signal when treated with anti-CD90 antibody (Fig. 
8B).Morphological studies showed that the majority of the isolated cells had a 
characteristic spindle-shaped morphology of smooth muscle cells. Some of the cells 
exhibited a flattened morphology (Fig. 8C, white arrow).  
 
 
 
 
 
 
 
 
 
Fig. 8 Fluorescence-activated cell sorting (FACS) analysis of isolated rat aorta vascular smooth muscle cells 
versus fibroblasts. (A) STO-fibroblasts as positive control for CD90 and (B) isolated rat VSMCs were 
incubated with FITC conjugated anti-CD90 (1:100, 4°C, 1 h) before analyzing in a flow cytometer. 10,000 
events were acquired for each sample on a histogram with blue laser canal (BL1-H) on the Y-axis. Cells that 
did not react with the anti-CD90 antibody were measured by light scattering. Differential interference 
contrast (DIC) image (C) of rat VSMCs. Curves represent incubated cells with anti-CD90 (red), with 
secondary antibody (violet), and cells without treatment (blue).   
P a g e  | 72 Results 
3.2 Isolated primary VSMCs expressed the smooth muscle marker proteins   
As reported in previous studies, smooth muscle specific proteins like smMHC, αSMA, 
desmin and calponin are commonly used as marker proteins to characterize isolated 
SMCs145. In order to determine the expression level of these marker proteins in the 
isolated cells, specific antibodies against those proteins were used for detection by 
immunofluorescence microscopy. The isolated cells showed a strong immuno-reaction 
with antibodies against desmin, α-SMA and smMHC (Fig. 9A-C). As expected, antibodies 
against α-SMA detected the protein in both smooth muscle cells and fibroblast as the 
latter one expresses α-SMA as well.   
Fig. 9 Indirect immunofluorescence analysis of marker proteins of isolated VSMCs. Immmunostaining of 
desmin (A), smMHC (B) and α-SMA (C) in isolated cells. In order to characterize isolated cells by smooth 
muscle marker proteins, freshly isolated cells were seeded on 0.1% gelatin pre-coated coverslips overnight, 
and fixed with 0.4% PFA for 15 min. After permeabilization with 0.4% triton X100 (15 min), cells were 
immunostained against (A) desmin (1:500), (B) smMHC (1:500), and (C) α-SMA (1:1000). The actin 
cytoskeleton and the cell nucleus were stained with Alexa-555 conjugated phalloidin (1:1000, red) and 
Hoechst 33342 (1:1000, blue). Scale bars represent 20 µM.    
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3.3 Immunofluorescence studies demonstrated co-localization of SYNPO2, 
smMHC, and α-SMA  
Furthermore, co-staining of VSMCs that were already treated with anti-SYNPO2 
antibodies (2nd antibody anti-rabbit Alexa-555), with anti-smMHC, or with anti α-SMA (2nd 
antibody anti-mouse Alexa-488), respectively, showed a high degree of colocalization of 
SYNPO2 & α-SMA. In case of the co-staining with SYNPO2 and smMHC the staining was 
less intense and more diffuse (Fig. 10).  
Fig. 10 Visualization of SYNPO2 and the contractile marker proteins, smMHC and α-SMA. PFA (4%) fixed and 
Triton x100 (0.4%) permeablized primary rat VSMCs (Passage 1) treated with rabbit anti-SYNPO2 antibodies 
(1:5000) and (A) monoclonal mouse anti-smMHC (1:500) or (B) anti-α-SMA (1:1000) antibodies. As 
secondary antibodies goat anti-rabbit IgG (1:1000), conjugated Alexa 555 and goat anti-mouse, conjugated 
to Alexa 488 (1:1000), antibodies were used. Scale bars represent 10 µm.  
 
3.4 Alteration of marker proteins during phenotype switch 
The expression level of selected proteins typical for the differentiated smooth muscle cell 
phenotype was determined in two different ways. Firstly, the expression levels of further 
marker proteins were determined on mRNA level by using qRT-PCR. Additionally, Western 
blotting was used to determine expression levels of caldesmon and ß-actin on the protein 
level. As shown in Fig. 11A, the mRNA of the smooth muscle specific proteins vimentin, 
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smoothelin, and sm22 were more abundant on the first day of isolation than at passage 3 
(about day 20 after isolation). The significance level of vimentin expression was p<0.001 
as determined by a two-tailed student’s t-test. For smoothelin, caldesmon, and SM22 the 
significance was p<0.0001. Expression of SYNPO2 has never before been investigated as a 
result of phenotypic switching of vascular smooth muscle cells. We found a down-
regulation of SYNPO2 upon dedifferentiation of vascular smooth muscle cells with a 
significance level of p<0.01.  
The primers used for the amplification of caldesmon were selected in a way that both h- 
and l-caldesmon (hCaD and lCaD) would be amplified. Thus, the differentiation between 
h- and l-caldesmon was achieved by Western blot analysis.  
While lCaD is scarcely found in native VSMCs, Western blot analysis during isolation and 
initial cultivation of VSMCs showed (Fig. 11B) that increasing cultivation time led to 
upregulation of lCald, while at the same time hCaD levels declined in passage 1 (Fig. 11C). 
Although hCaD decreased, the onset of hCaD down-regulation was delayed and reached 
only its full extend when lCaD was thoroughly upregulated. Parallel to augmented lCaD 
levels ß-actin expression increased. Normalization of these proteins to GAPDH showed, 
the typically in synthetic smooth muscle cells expressed proteins lCaD and ß-actin were 
higher as early as passage 1. Low-caldesmon (Fig. 11E) was 12-fold higher in passage 1. In 
passage 2 the lCaD was higher by factor 10, and in passage 3 by the factor 8.5. ß-actin 
(Fig. 11D) was upregulated 1.3-times on protein level in the first passage and did not 
undergo further changes at higher passages. The results on protein level for ß-actin 
differed from those obtained by qRT-PCR demonstrating a downregulation between day 1 
and the third passage of about 2.8 fold. 
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Fig. 11 Expression analysis of marker proteins in primary rat VSMCs. Quantitative RT-PCR from VSMCs from 
rat aorta on day 1 of isolation and passage 3 of cultivation. QRT-PCR was performed from three 
independent experiments in triplicates using 20 ng cDNA in each reaction. GAPDH was used as an 
endogenous control. Expressions levels are shown as the expression of target mRNA from cells of passage 3. 
Histograms show means ± SEM (n=3), ***p< 0.0001; **p<0.001; *p<0.01 (A). Western blot analysis of 
whole cell extracts at day 1 of isolation, passage 1, passage 2, and passage 3 (B-E). Proteins were separated 
on a 10% SDS-PAGE, blotted on nitrocellulose membrane and probed with antibodies directed against 
hCaD, lCaD, ß-actin, and GAPDH (B). Protein content as determined from IR Dye signals of the conjugated 
secondary antibodies: hCaD against GAPDH (C), β-actin versus GAPDH (D), and lCaD against GAPDH (E).  
 
3.5 Phenotype switch of VSMCs alters subcellular distribution of SYNPO2 
In striated muscle cells shuttling of SYNPO2 between the nucleus and cytoplasm depends 
on differentiation of the cells and exposure to stress like heat shock77, 101. Although 
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SYNPO2 is abundant in smooth muscle its subcellular localization during differentiation 
and dedifferentiation of smooth muscle cells is not known. As shown in Fig. 12, the 
subcellular localization of SYNPO2 is depends on vascular smooth muscle phenotype. On 
day 1 of isolation rat aorta smooth muscle cells present a differentiated smooth muscle 
phenotype. At this stage SYNPO2 was mainly found in the cytoplasm (Fig. 12A), where it 
seems to be uniformly spread. In the second passage, however, cells were already 
dedifferentiated presenting a synthetic phenotype. Dedifferentiation showed a serious 
impact on the localization of SYNPO2 (Fig. 12B). Most of the SYNPO2 was localized into 
the nucleus and nucleolemma. SYNPO2 that remained in the cytoplasm assembled as 
broad subcortical zone below the adhesion sites of the cells. The quantitative analysis of 
the subcellular localization of SYNPO2 based on immunofluorescence data (Fig. 12C) 
showed that upon (de)differentiation the distribution between the nucleus and the 
cytoplasm was nearly reversed. On day 1 of isolation SYNPO2 was found in 16.45% of the 
isolated VSMCs in the nucleus, but in the majority of the cells SYNPO2 was localized into 
the cytoplasm. In contrast, at passage 2 SYNPO2 showed a strong nuclear localization in 
89.45% of the cells. Interestingly, the subcellular fractionation of VSMCs showed different 
distribution for SYNPO2 isoforms in the cytoplasm and the nucleus (Fig.12D).   
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Fig. 12 Subcellular localization of synaptopodin 2 during isolation and cultivation of primary VSMCs. (A) Cells 
from day 1 (contractile phenotype) and (B) passage 2 (non-contractile phenotype) were grown on cover 
slips, fixed with 4% PFA, and permeabilized with 0.4% Triton X-100. Subcellular localization of SYNPO2 was 
detected with a polyclonal anti-SYNPO2 antibody and visualized using an anti-rabbit Alexa Fluor®488 
antibody. The actin cytoskeleton and the cell nucleus were visualized by Alexa Fluor®555 phalloidin and 
Hoechst 33342, respectively. Scale bars represent 20 µm. (C) Statistical analysis of SYNPO2 distribution in 
the nucleus versus the cytoplasm during isolation and cultivation. The histogram shows mean ± SEM (n=4, 
150 cells from each experiment) from four independent experiments performed in triplicate ***p<0.0001. 
(D) SYNPO2 isoforms were anaylzed using subcellular fractionation and Western blot assays (passage 3). 
Membrane was probed with anti LaminB1 (abcam, 1:4000) and GAPDH (Sigma-Aldrich, 1:25000) to 
characterize nucleus and cytoplasmic fractions. Distribution of SYNPO2 isofroms was detected by anti-
SYNPO2 (1:50000).  
 
3.6 Controlling of phenotype switch using ECM proteins 
Previous studies reported, that the phenotypic switch in VSMCs is controlled by 
environmental conditions like extracellular matrix proteins8, 10. In order to mimic stiffness 
as found under atherosclerotic conditions, a polyacrylamide matrix with stiffness of 
approximately 55 kPa was used139 (The matrices were provided by Dr. Pfannkuche). The 
matrices were coated with the extracellular matrix proteins laminin 1 and collagen I, 
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respectively, in order to direct our isolated primary VSMCs to develop a differentiated or 
rather dedifferentiated phenotype. As a control, we used cells from the same passage 
that were cultivated on non-coated tissue culture dishes. The phenotypes were assigned 
according to the mRNA expression level and the expressed proteins, employing the same 
markers we used for our initial characterization (Fig. 13). On mRNA level, a slight, but 
non-significant upregulation of vimentin was detected, while ß-actin, smoothelin, and 
SM22 were ~1.4, ~1.8, and ~2 fold, respectively, upregulated when VSMCs were cultured 
on laminin. In cells cultivated on laminin, Cald1 and SYNPO2 were markedly upregulated 
by the factors 6 and 3.2, respectively (Fig. 13A). Upregulation of ß-actin, smoothelin, 
SM22, and Cald1 indicated the presence of a contractile phenotype of VSMCs cultivated 
on laminin. Western blot analysis using antibodies directed against ß-actin and caldesmon 
and GAPDH as internal control, confirmed the on laminin versus collagen I established 
phenotypes (Fig. 13B-E). In all cells, independent whether cultivated on laminin or 
collagen I coated matrices or on non-treated culture dishes, we found hCaD to be 
expressed, but reduced to a very low level in cells cultivated on non-treated dishes. The 
increase of hCaD is remarkable when cultured on pre-coated polyacrylamide matrices. 
While hCaD decreases to a minimum in uncoated dishes, it was highly upregulated by the 
factors 8 on collagen I, and 19 when cultivation took place on laminin coated matrices. 
hCaD presented itself as doublet when cells were grown on non-treated culture dishes. 
When calculating the expression of h-caldesmon, both bands were accounted for. 
Interestingly, lCaD was slightly, but not significantly upregulated in cells grown on 
laminin-coated matrices as compared to those VSMCs that were cultivated on non-
treated dishes (Fig. 13E). In contrast, cells grown on collagen I coated matrices showed a 
significant (p<0.001) 3.2 fold upregulation of lCaD.  
On protein level, a slightly higher expression of ß-actin was detected in cells cultivated 
on laminin than what we expected from our previously determined mRNA-level of cells 
cultivated on laminin versus collagen I pre-coated polyacrylamide matrices (Fig. 13D). 
Expression of ß-actin compared to our control cells was significantly (p<0.0001) increased 
in cells grown on laminin-coated matrices (factor 9.5) and those grown on collagen I 
(factor 5).  
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Fig. 13 Characterization of VSMCs cultivated on polyacrylamide matrices coated with extracellular matrix 
proteins. VSMCs from passage 2 were seeded on laminin or collagen I coated polyacrylamide matrices 48 h 
prior the experiments. For mRNA quantification, cells were harvested mechanically, total-RNA was isolated 
using a Maxwell 16 LEV RNA tissue kit, and cDNA was synthesized with a QuantiTect Reverse Transcription 
Kit. Real-time PCR was carried out from three independent experiments in triplicate, using GAPDH as an 
endogenous control. Expression levels are measured as an expression of target mRNA in on collagen I 
cultivated cells (gray bars) relative to that of on laminin grown cells (black bars) (A). For semi-quantitative 
Western blots (B) cells were disconnected using RIPA buffer. The proteins were separated on 10% SDS 
polyacrylamide gels, transferred in a tank blot apparatus to nitrocellulose and probed with anti-ß-actin, 
anti-caldesmon and anti-GAPDH antibodies. The statistical results of these analyses are shown in the 
following: hCaD-GAPDH ratio (C), ß-actin-GAPDH ratio (D), and lCaD-GAPDH ratio (E). For all experiments 
control cells of the same passage were grown in untreated culture dishes. Histograms show means ± SEM 
(n=3), ***p< 0.0001; **p<0.001; *p<0.01. 
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3.7 Cultivation the cells on ECM proteins pre-coated matrices alter subcellular 
localization of SYNPO2 
The phenotype of VSMCs was determined using qRT-PCR and Western blotting, when 
cultivated on laminin or collagen I coated polyacrylamide matrices. In the following we 
focused on the shape of the cells grown under these conditions and the subcellular 
localization SYNPO2 occupies in the established phenotypes. In agreement with the 
literature146, we observed spindle form, elongated VSMCs upon cultivation on laminin 
coated matrices (Fig. 14B). In contrast, cells grown on collagen I had a flattened, 
widespread appearance typical for dedifferentiated VSMCs (Fig. 14A).  
Using a polyclonal antibody against SYNPO2, combined with a Fluorescent labeled 
secondary antibody, we detected endogenous SYNPO2 in the cytoplasm and around the 
nucleus of VSMCs with the characteristics of differentiated smooth muscle cells. In 
contrast, most of the cells grown under conditions promoting a dedifferentiated 
phenotype exhibited the endogenous SYNPO2 in the nucleus (Fig. 14A). The difference of 
the SYNPO2 distributions between both phenotypes was highly significant (p<0.0001). 
 
 
 
Fig. 14 On laminin coated polyacrylamide matrices cultivated VSMCs develop a contractile phenotype. 
VSMCs passage 2 was seeded on collagen I (A) or laminin (B) coated polyacrylamide matrices with a 
stiffness of 55 kPa 48 h prior experiments. Cells were fixed with 4% PFA, permeabilized with Triton-X100, 
and blocked with 5% BSA in PBS for 1h prior incubation with antibodies. Synaptopodin 2 was detected with 
a polyclonal anti-SYNPO2 antibody (1:5000) and visualized using an Alexa®488 conjugated secondary 
antibody (1:1000). F-actin was visualized using Alexa®555 conjugated phalloidin (0.2 U/ml), the nucleus was 
stained with Hoechst 33342 (10 µg/ml). Quantitative analysis shows a significant reduction in the number of 
nuclear synaptopodin 2 displaying cells grown on laminin, while those grown on collagen I show a nuclear 
distribution (C). Means ± SEM, n=4 (150 cells from each experiment), ***p< 0.0001. Scale bars represent 
20 µm. 
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3.8 Actin cytoskeleton turnover affects subcellular distribution of SYNPO2 
In order to investigate whether actin cytoskeleton turnover affects subcellular localization 
of SYNPO2, VSMCs were treated with 0.5 µM cytochalasin D (CCD) and 0.1 µM 
jasplakinolide (JASP), or with DMSO (0.04%) as vehicle control, respectively. Cells 
cultivated on collagen I coated matrices showed a strong accumulation of SYNPO2 in the 
nucleus and a diffuse staining in the cytoplasm (Fig. 15A). When cells were grown on 
collagen I coated polyacrylamide matrices and treated with either CCD or JASP, the most 
of the stress fibers were disrupted. The majority of SYNPO2 localized in the nucleus, 
regardless whether the actin cytoskeleton was treated with CCD or JASP (Fig. 15B-C). In 
contrast, when the actin cytoskeleton was not completely impaired, SYNPO2 staining was 
also found in the cytoplasm where it co-localized with the remaining F-actin structures 
(Fig. 15B & C, insets). F/G-actin ratio was measured, in order to quantify and to compare 
the F/G-actin ratio from the cells treated with CCD, JASP and also vehicle control. Cells 
seeded on collagen I coated matrices demonstrated a significant reduction of G-actin, 
when the cells were treated with JASP, while cells treated with CCD did not demonstrate 
significant changes in the F/G-actin ratio as compared to vehicle control (Fig. 15D).  
Fig. 15E-G shows the distribution of SYNPO2 in cells grown on a laminin coated 
polyacrylamide matrix under control conditions (E) and after treatment with CCD (F) or 
JASP (G). The vehicle control with DMSO (E) showed the same cytoplasmic distribution, 
we observed earlier. Manipulating the actin cytoskeleton by application of CCD (F) or JASP 
(G) caused a disruption of stress fibers as shown by IF, which in turn accompanied by a 
strong enrichment of SYNPO2 around the nucleus. However, quantification of F/G-actin 
ratio demonstrated a significant increase of F-actin, when the cells were treated with 
JASP as compared to the vehicle control (Fig. 15H). In cells that had still some actin fibers 
we observed a colocalization of SYNPO2 with F-actin in the cytoplasm (see inset Fig. 15F & 
G). 
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Fig. 15 Subcellular 
distribution of SYNPO2 
during actin cytoskeleton turnover. VSMCs passage 2 (non-contractile) seeded on laminin or collagen I 
precoated polyacrylamide were treated with 0.04% DMSO as vehicle control (A & E) or in addition with 
0.5 µM CCD (B & F) or 0.1 µM JASP (C & G) and incubated for 1 h at 37°C, 5% CO2. Cells were used to 
analyze F/G-actin ratio (D & H) or fixed with 4% PFA, permeabilized with 0.4% Triton-X100, and blocked 
with 5% BSA in PBS for 1h prior incubation with antibodies. SYNPO2 was detected with a polyclonal anti-
SYNPO2 antibody (1:5000) and visualized using an Alexa®488 conjugated secondary antibody (life 
technology, 1:1000). F-actin was visualized using Alexa®555 conjugated phalloidin (life technology, 1:1000), 
the nucleus was stained with Hoechst 33342 (1:1000). F/G-actin ratio experiment was performed by F/Actin 
kit (Cytoskeleon) and the results are presented as means ± SEM from three independent experiments 
performed in triplicate, performed in triplicate (D & H). Scale bars represent 20 µm. 
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3.9 Heat Shock Stress did not affect the Subcellular Localization of SYNPO2 in 
VSMCs 
Previous reports showed that heat shock induces nuclear accumulation of GFP-SYNPO2 
(murine) in C2C12 myoblasts77. In order to test whether heat shock causes the same 
subcellular accumulation of SYNPO2 in VSMCs, in three independent experiments, heat 
shock at 43°C was applied for 90, 120, and 150 min respectively. With exception of heat 
exposure for an elongated time of 150 min, no change of the endogenous SYNPO2 
distribution was observed (Fig. 16). This means, that the majority of the SYNPO2 protein 
was still in the cytoplasm of the VSMCs. Elongated exposure to high temperature (150 
min at 43°C) resulted in a more punctuated distribution of SYNPO2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16 Distribution of smooth muscle cells SYNPO2 is independent of heat stress. Isolated VSMCs were 
seeded on coverslips (precoated with 0.1% gelatin), and grown for 12 h before heat stress was applied. Cells 
were incubated at 43°C for 90, 120, and 150 min in a pre-warmed water bath. Cells were immunostained 
with anti SYNPO2 antibody (1:5000) as first antibody and Alexa-488 conjugated goat anti-rabbit IgG (1:1000) 
for 1h at RT. The cell nucleus was visualized by using Hoechst 33342 (1:1000). Scale bar represents 20 µm. 
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3.10 Subcellular distribution of SYNPO2 is controlled by cAMP 
Although, in the past years, several studies on GFP-SYNPO2 (murine) showed that an 
increased cAMP level in striated muscles is essential for phosphorylation and in turn its 
subcellular distribution in cardiac myocytes100, 101, this mechanism in VSMCs has never 
been investigated before.  
In order to study the effect of cAMP dependent signaling pathways on trafficking of 
SYNPO2, cells were treated with agonist, which activate adenylyl cyclase and therefore 
raise the level of cAMP in the cells. While under control conditions (0.01% DMSO) 
SYNPO2 was found in the cell cytoplasm and around the nucleus (Fig. 17A), urocortin (Fig. 
17B), and forskolin (Fig. 17D) treated cells demonstrated a strong accumulation of 
SYNPO2 to the nucleus. Cells treated with the cAMP analogue Sp-5,6-DCl-cBIMPS (5, 6- 
Dichloro-1- ß- D- ribofuranosylbenzimidazole- 3', 5'- cyclic monophosphorothioate, Sp-
isomer) also increased SYNPO2 accumulation to the nucleus (Fig. 17C). Treatment of the 
cells with a combination of forskolin and IBMX (phosphodiestrase inhibitor) resulted in a 
diffuse distribution of SYNPO2 in the cells, with a markedly derogated concentration at 
the cell boundaries/leading edge and an accumulation in and around the cell nucleus (Fig. 
17). Statistical analyses demonstrated a significant increase in the number of nuclear 
SYNPO2-displaying VSMCs after upregulation of cAMP by urocortin, forskolin, and Sp-5,6-
DCl-cBIMPS. However, in the case of cells, treated with both forskolin and IBMX, the 
number of nuclear SYNPO2-displaying cells was significantly decreased (Fig. 17F).  
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Fig. 17 cAMP-induced shuttling of SYNPO2 in VSMCs. VSMCs were treated with 0.01% DMSO as vehicle 
control (A), 100 nM urocortin (B), 10 µM Sp-5,6-DCl-cBIMPS (C), 10 µM forskolin (D), or 10 µM forskolin-
IBMX (E) for 1 h and immunostained with anti-SYNPO2 (1:5000, green). Cell nucleus (blue) and the actin 
cytoskeleton (red) were visualized with Hoechst 33342 (1:1000) and Alexa-555 conjugated phalloidin 
(1:1000). Statistical analysis was performed using two-sample Student's t test (F). Results are shown as the 
means ± SEM from four independent experiments performed in triplicate (150 cells from each experiment). 
Scale bars represent 20 µm. N>C, N<C and N=C represent nuclear, cytoplasmic, and equally distributed 
SYNPO2-displaying cells, respectively. 
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3.11 Inhibition of PKA and CaMK-II reduced the accumulation of SYNPO2 in the 
nucleus of VSMCs 
In passages 2-4, where SYNPO2 mainly localized to the nucleus (Fig. 18A), inhibition of 
PKA by Rp-8-PIP-cAMPs (8-Piperidinoadenosine-3′,5′-cyclic monophosphorothioate, Rp-
isomer sodium salt) reduced the amount of nuclear SYNPO2, and demonstrated a diffuse 
localization around the cell nucleus (Fig. 18B). Similarly to the Rp-8-PIP-cAMPs, H89 (N-[2-
[[3-(4-Bromophenyl)-2-propenyl]amino]ethyl]-5-isoquinolinesulfonamide 
dihydrochloride) treated cells demonstrated a reduction in nuclear SYNPO2, whereas 
cytoplasmic distribution of SYNPO2 was more consistent (Fig. 18C). Inhibition of CaMKII 
with a commercially available inhibitor KN93 (N-[2-[[[3-(4-Chlorophenyl)-2-
propenyl]methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-
methoxybenzenesulphonamide) resulted in a slight reduction of nuclear SYNPO2 as 
compared to the PKA inhibition (Fig. 18D). Further quantitative analysis of treated cells 
with inhibitors as compared to the vehicle controls indicated a significant reduction of the 
number of nuclear SYNPO2-displaying cells (Fig. 18E).  
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Fig. 18 Inhibition of both PKA and CaMKII reduced nuclear accumulation of SYNPO2 in the isolated VSMCs. 
VSMCs from passage 2 to 4 were treated with 0.01 % DMSO (A) as vehicle control, 100 µM Rp-8-PIP-cAMPs 
(B) and 10 µM H89 (C) as PKA inhibitors or 10 µM KN93 (D) as a CaMKII inhibitor for 1 h. Statistical analysis 
(E) demonstrated at least four independent experiments performed in triplicate (150 cells from each 
experiment). Means ± SEM are shown. Scale bars represent 20 µm. N>C, N<C and N=C represent nuclear, 
cytoplasmic, and equally distributed SYNPO2-displaying cells, respectively. 
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3.12 ROCK signaling does not affect subcellular localization of SYNPO2 
Treatment of VSMCs, passage 2-4, with the ROCK inhibitor, Y-27632 (10 µM) caused 
disruption of stress fibers (Fig. 19B), while vehicle controls showed the characteristic actin 
cytoskeleton (Fig. 19A). However, this disruption of actin fibers was not accompanied by a 
change of the subcellular SYNPO2 distribution. Statistical analysis using Student's t-test 
did not show any significant alteration in subcellular localization of SYNPO2 in Y-27632 
treated cells compared to the control.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19 Inhibition of ROCK had no effects on the subcellular localization of SYNPO2. Cells from passage 3, 
seeded on 0.1% gelatin pre-coated coverslips, and incubated in serum free medium (2 h) were grown 
without treatment (A) as vehicle control or were treated with 10 µM Y-27632 (B) as a ROCK inhibitor for 1 h. 
For statistical comparison between Y-27632 treated cells and vehicle (C), two-sample Student's t test was 
used. A p value < 0.05 was considered statistically significant. Scale bars represent 20 µm and results are 
shown as means ± SEM (n=4), for 150 cells from each experiment. N>C, N<C and N=C represent nuclear, 
cytoplasmic, and equally distributed myopodin-displaying cells, respectively. 
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3.13 Treatment with okadaic acid resulted in a reduction of nuclear SYNPO2- 
displaying cells 
In order to investigate whether protein phosphatases (PP1 and PP2A) affect the 
distribution of SYNPO2, VSMCs were incubated with okadaic acid (OA) to provide a 
complete inhibition of both phosphatases. Inhibition of phosphatases reduced 
significantly the number of nuclear SYNPO2-displaying cells (Fig. 20B). As expected from 
the results (Fig. 17 and 18), phosphorylation seems to be crucial for nuclear import and 
export of SYNPO2. Quantitative analysis of cells displaying nuclear SYNPO2 demonstrated 
a significant accumulation of SYNPO2 in the cytoplasm upon the treatment with OA (Fig. 
20C).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20 Okadaic acid induced accumulation of SYNPO2 in the cytoplasm. After serum depletion for 2 h, 
untreated cells (A) or cells incubated with the phosphatase inhibitor okadaic acid (100 nM) for 1 h (B) were 
fixed, permeabilized, and treated with anti-SYNPO2, Phalloidin-Alexa555, and Hoechst 33342 as described 
before. Scale bars represent 20 µm. Quantitative statistical analysis (C), was performed with the two-
sample Student's t-test. At least four independent experiments were performed in triplicate. Results are 
shown as means ± SEM. N>C, N<C and N=C represent nuclear, cytoplasmic, and equally distributed 
myopodin-displaying cells, respectively. 
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3.14 Characterization of expression level of 14-3-3 isoforms in VSMCs 
Previous works already showed that 14-3-3 proteins are an important player at the 
subcellular shuttling of SYNPO2 in the cell100, 101. This could of course also imply a 
functional relevance of its isoforms at the differentiation states of VSMCs and in turn also 
at the trafficking of SYNPO2. However, no reports are currently available to test the 
functionality of the 14-3-3 isoforms experimentally in this term. Accordingly, we next 
tested the hypothesis that 14-3-3 isoforms change their expression level during 
phenotype switch of VSMCS and therefore they regulate different step of this shuttling. 
To test this, expression level of seven 14-3-3 isoforms were analyzed using quantitative 
real-time PCR. As shown in Fig. 21, the mRNA level of the 14-3-3τ, η, and ζ were more 
abundant on the first day of isolation than at passage 3, while the mRNA level of isoform 
σ was higher at passage 3. The significance level of 14-3-3η expression was p<0.02 as 
determined by a two-tailed student’s t-test. For 14-3-3τ, and ζ the significance was 
p<0.001. We found a higher expression of 14-3-3σ upon dedifferentiation of VSMCs with 
a significance level of p<0.005. Interestingly, no significant changes in mRNA level of the 
isoforms β, γ, ε was detected at passage 3 in VSMCs compared to cells from day 1.  
 
 
 
 
 
 
 
 
 
 
Fig. 21 Expression analysis of 14-3-3 isoforms in primary rat VSMCs. Quantitative RT-PCR from VSMCs from 
rat aorta on day 1 of isolation and passage 3 of cultivation. qRT-PCR was performed from three 
independent experiments in triplicates using 20 ng cDNA in each reaction. GAPDH was used as an 
endogenous control. Expression levels are shown as the expression of target mRNA from cells of day 1. 
Histograms show means ± SEM (n=3), ***p< 0.0001; **p<0.001; *p<0.01 (A).  
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3.15  Analysis of subcellular localization of SYNPO2 and its interaction with 14-3-
3β/γ, and importinα using fluorescent fused proteins and BIFC assay 
In 2005 and 2007, Faul et al. showed that interaction of SYNPO2 with 14-3-3β and 
importinα leads to its accumulation in the nucleus of C2C12 cells100, 101. Moreover, it is 
already reported that of the seven isoforms comprising this family, 14-3-3-γ and -β have 
been shown to be expressed in VSMCs147-150. Accordingly, we next investigated the 
subcellular localization of SYNPO2, 14-3-3γ/β, and importinα and their interaction 
together in living cells by designing and combining different fluorescent proteins (Fig. 22 
A and B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 22 Schematic illustration of constructs used for SYNPO2, 14-3-3γ/β & importinα interaction and 
localization analysis by BIFC and a FACS-BIFC based assays. (A) Schematic representation of SYNPO2, 14-3-
3β/γ and importinα proteins fused to YFP, CFP, and (B) Non-fluorescent fragments of YFP (ΔC-YFP-1-158, 
ΔN-YFP-159-238) fused to N-terminus of SYNPO2, 14-3-3β/γ and importinα proteins.  
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In order to validate the accuracy and the expression level of the fluorescent fused 
proteins, designed vectors were transiently transfected in HEK293 cells by the calcium 
phosphate method and in each case Western blotting was used to demonstrate the 
results. The fluorescent fused proteins were detected by probing the membrane with 
rabbit anti-YFP/CFP antibody. Detected bounds on membrane demonstrated calculated 
molecular mass for both N-or C-terminus fluorescent fused SYNPO2, 14-3-3γ (Fig. 23A) 
and for 14-3-3β, and importinα (Fig. 23B). BIFC constructs were detected using a mouse 
polyclonal anti-GFP antibody (Fig. 23C).    
 
 
 
Fig. 23 Expression analysis of fluorescent fused proteins. Samples of (A) N- and C-terminus CFP fused 14-3-
3γ around 55 kDa (calculated MW= 55610 Da), N- and C-terminus YFP fused SYNPO2 at around 102 kDa 
(Calculated MW= 102553 Da) and, (B) N- and C-terminus CFP fused importinα around (calculated MW= 
55669 Da) and 14-3-3β around (calculated MW=55669 Da) were subjected to SDS-PAGE and Western 
blotting. C) Protein expression analysis of ΔN-, ΔC-YFP fused SYNPO2, 14-3-3γ/β, and Importinα showed also 
MW of each protein as same as we calculated for each by Expasy website.  
 
3.16 Subcellular localization of YFP-fused SYNPO2 & CFP-fused 14-3-3γ/β, 
importinα 
Fluorescent fused proteins allowed subcellular localization, colocalization and interaction 
studies, between SYNPO2, 14-3-3γ/β and importinα in the cellular context. In order to 
perform the localization studies, N- and C-terminus YFP fused SYNPO2, N- and C-terminus 
CFP-fused-14-3-3γ or β and N- and C-terminus CFP-fused importinα were used. YFP-
SYNPO2 was strongly accumulated in the nucleus of HEK293 cells, either in form of a loop 
structure (Fig. 24A, white arrow), which seems to be an actin loop as described before77 
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and/or in forms similar to nuclear bodies as reported earlier151 (Fig. 24A´, arrowhead). 
However, cells transfected with SYNPO2-YFP, C-terminal fused YFP, mostly showed a 
diffuse distribution of SYNPO2 in both cell nucleus and cytoplasm of HEK293 cells. 
Notably, it did not detect definable structure in this case (Fig. 24B & B´). CFP-14-3-3γ was 
mainly accumulated in the cytoplasm of HEK293 cells (Fig. 24C & C´), which in turn was 
also detected for 14-3-3γ-CFP, respectively (Fig. 24D & D´). CFP-14-3-3β (Fig. 24E & E´) 
and 14-3-3β-CFP (Fig. 24F & F´) were mainly localized in the cytoplasm of transfected 
cells. HEK293 cells transfected with CFP-importinα (Fig. 24G & G´) and importinα-CFP (Fig. 
24H & H´) showed a strong accumulation of importinα in the cell nucleus and a slight 
distribution in the cytoplasm. Interestingly, cells transfected with both constructs of 
importinα demonstrated also a nucleolar or nuclear bodies similar localization of 
importinα in both cases (Fig. 24G to H´, white arrows).  
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Fig. 24 Subcellular distribution of fluorescent fusion proteins in living cells detected by confocal laser 
scanning microscopy. Confocal fluorescence images of HEK293 cells transiently transfected with 300 ng of 
plasmids expressing the indicated YFP fused SYNPO2 (A & B) and CFP fused 14-3-3γ (C & D), 14-3-3β (E & F), 
and importinα (G & H) by the calcium phosphate method. CFP-fluorescent emission of transfected cells is 
shown in blue (excitation 458 nm, emission 465–495 nm) and YFP-fluorescent emission is shown in yellow 
(excitation 514 nm, emission 525–565 nm). At least three independent experiments were performed in 
triplicate. Scale bars present 20 µm.  
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3.17 Analysis of SYNPO2, 14-3-3 γ/β and importinα interaction by using BIFC 
In order to investigate the physical interaction between SYNPO2, 14-3-3β/γ, and 
importinα in the living cell, it was tested whether both ΔN-YFP-SYNPO2 and ΔC-YFP-
SYNPO2 interact with ΔN-, ΔC-YFP fused 14-3-3β/γ and importinα based on fluorescence 
development according to BIFC principle125. 
3.17.1 SYNPO2 interacts with 14-3-3γ in the cytoplasm and not in the nucleus 
To analyze the interaction between SYNPO2 and 14-3-3γ, cells were transiently 
cotransfected with equal amounts (300 ng) of the constructs and incubated for 24 to 48 h 
at a humidified atmosphere. Fig. 25 shows representative images of both the control and 
the interaction experiments. Control experiments (Fig. 25A & D) did not show any 
fluorescence development between non-fluorescent fragments (ΔC-YFP-1-158 and ΔN-
YFP-159-238) with ΔN-YFP-14-3-3γ and/or ΔC-YFP-14-3-3γ fragments. Interaction 
between both ΔN- and ΔC-YFP fused SYNPO2 with 14-3-3γ was shown as fluorescence 
development that is shown in Fig. 25B and E. Interaction between 14-3-3γ and SYNPO2 
was mainly detected in the cytoplasm and not in the nucleus. However, HEK293 cells 
cotransfected with ΔN-YFP-14-3-3γ and ΔC-YFP-SYNPO2 demonstrated pointed structures 
in the cytoplasm (Fig. 25E, white arrow), while the interaction between ΔC-YFP-14-3-3γ 
and ΔN-YFP-SYNPO2 was diffuse in the cytoplasm (Fig. 25B).  
A FACS-BIFC based analysis confirmed the results from confocal imaging (Fig. 25C, F). 
Around 11% of HEK293 cells cotransfected with ΔC-YFP-14-3-3γ and ΔN-YFP-SYNPO2 (Fig. 
25C) demonstrated a positive fluorescence development as compared to the negative 
control (ΔN-YFP & ΔC-YFP), while cells cotransfected with ΔN-YFP-14-3-3γ and ΔC-YFP-
SYNPO2 showed a population of around 12% with positive fluorescence (Fig. 25F).  
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Fig. 25Interaction between SYNPO2 and 14-3-3γ takes place in the cytoplasm of HEK293 cells. Transiently 
cotransfected HEK293 cells, seeded on ECL precoated coverslips with 300 ng of non-fluorescent plasmids 
using the calcium phosphate method. Confocal fluorescence images of control cells, cotransfected with ΔC-
YFP-14-3-3γ/ΔN-YFP (A), ΔN-YFP-14-3-3γ/ΔC-YFP (D) and cells cotransfected with ΔC-YFP-14-3-3γ/ΔN-YFP-
SYNPO2 (B), ΔN-YFP-14-3-3γ/ΔC-YFP-SYNPO2 (E). YFP-fluorescent emission is shown in yellow (excitation 
514 nm, emission 525–565 nm). FACS-BIFC results from 10,000 events for ΔC-YFP-14-3-3γ/ΔN-YFP-SYNPO2 
(C), ΔN-YFP-14-3-3γ/ΔC-YFP-SYNPO2 (F) as histogram. ΔC-YFP/ΔN-YFP cotransfected HEK293 cells was used 
as a control for FACS analysis (violet curve). At least three independent experiments were performed in 
triplicate. Scale bars present 20 µm.  
 
3.17.2 SYNPO 2 and 14-3-3β accumulate and form loop-like complexes in the nucleus 
In order to analyze the interaction between SYNPO2 and 14-3-3β, transiently 
cotransfected HEK293 cells were used for both confocal imaging and FACS-BIFC based 
assay as described. Cells cotransfected with ΔN-YFP-SYNPO2 and ΔC-YFP-14-3-3β (Fig. 
26B) demonstrated an interaction between SYNPO2 and 14-3-3β due to the fluorescence 
development as compared to the control cells cotransfected with ΔC-YFP-14-3-3β/ΔN-YFP 
(Fig. 26A). Interestingly, confocal fluorescence images demonstrated a nuclear 
accumulation of SYNPO2-14-3-3β complex and protein aggregate in the cell (Fig. 26B, 
white arrow). Validation of the results by FACS-BIFC based assay (Fig. 26C) showed a 
population of around 10% positive cells as compared to the negative control (ΔN-YFP & 
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ΔC-YFP). In HEK293 cells cotransfected with ΔC-YFP-SYNPO2 and ΔN-YFP-14-3-3β using 
calcium phosphate method, a nuclear localization of SYNPO2 and 14-3-3β was detected 
(Fig. 26E). Interestingly, ΔC-YFP-SYNPO2/ΔN-YFP-14-3-3β transfected cells demonstrated 
an accumulation and/or colocalization of SYNPO2-14-3-3β complex in the nucleus in form 
of a loop (Fig. 26E, white arrows) as we detected before (see Fig. 24A). Quantitative 
analysis of transfected HEK293 cells with ΔC-YFP-SYNPO2/ΔN-YFP-14-3-3β by FACS 
demonstrated 12% positive cell population of 10,000 events (Fig. 26F).   
Fig. 26 SYNPO2 and 14-3-3β localized and formed a loop structure in the nucleus. HEK293 cells were 
transiently cotransfected with 300 ng of ΔN-YFP & ΔC-YFP-14-3-3β (A), ΔN-YFP-SYNPO2 & ΔC-YFP-14-3-3β 
(B), ΔC-YFP & ΔN-YFP-14-3-3β (D), and ΔC-YFP-SYNPO2 & ΔN-YFP-14-3-3β (E) using the calcium phosphate 
method. Quantitative FACS-BIFC analysis of 10,000 measured HEK293 cells cotransfected with ΔN-YFP-
SYNPO2 & ΔC-YFP-14-3-3β (C), and ΔC-YFP-SYNPO2 & ΔN-YFP-14-3-3β (F). ΔC-YFP/ΔN-YFP cotransfected 
HEK293 cells was used as a control for FACS analysis (violet curve). At least three independent experiments 
were performed in triplicate. Scale bars present 20 µm.   
 
3.17.3 Preferred interaction of SYNPO2 and importinα in the nucleus 
In order to investigate SYNPO2, importinα interaction in living cells, transiently 
cotransfected HEK293 cells seeded at 50% confluent on coverslips, were analyzed using 
an Olympus laser confocal microscope. HEK293 cells cotransfected with 300 ng of ΔN-
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YFP-SYNPO2/ΔC-YFP-importinα (Fig. 27B) demonstrated a nuclear accumulation and/or 
interaction of SYNPO2 and importinα, while control experiment with HEK293 cells 
transfected with ΔN-YFP/ΔC-YFP-importinα did not show any fluorescence development 
(Fig. 27A). FACS analysis showed a population of around 12% of the cells in which 
fluorescence was detected (Fig. 27C). Confocal fluorescence imaging of the cells 
cotransfected with 300 ng of ΔC-YFP-SYNPO2/ΔN-YFP-importinα showed a nuclear 
distribution and/or interaction of SYNPO2/importinα (Fig. 27E). Analysis of the transiently 
transfected cells with ΔC-YFP/ΔN-YFP-Importinα, which was used as control experiment, 
revealed no fluorescent signal (Fig. 27D). Quantitative FACS-BIFC analysis of cells 
transfected with ΔC-YFP-SYNPO2/ΔN-YFP-Importinα demonstrated around 8% positive 
population of fluorescence positive cells (Fig. 27F). In both cases of the interaction study, 
an interaction/colocalization of SYNPO2-importinα complex in form of a loop were 
detected (Fig. 27B & E, white arrows). 
Fig. 27 Imaging of SYNPO2, importinα interaction using BIFC assay. SYNPO2, importin interaction analysis 
demonstrated a nuclear colocalization of SYNPO2-importinα complex. Confocal fluorescence images of 
transiently transfected HEK293 cells with 300 ng of ΔN-YFP-SYNPO2/ΔC-YFP (A), ΔN-YFP-SYNPO2/ΔC-YFP-
Importinα (B), ΔC-YFP-SYNPO2/ΔN-YFP (D), and ΔC-YFP-SYNPO2/ΔN-YFP-Importinα (E). Quantitative FACS-
BIFC analysis of 10000 measured HEK293 cells, cotransfected with ΔN-YFP-SYNPO2/ΔC-YFP-Importinα (C), 
and ΔC-YFP-SYNPO2/ΔN-YFP-Importinα (F) as a comparison with ΔC-YFP/ΔN-YFP (violet curve) 
cotransfected HEK293 cells are shown. Scale bars present 20 µm.   
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3.18 Visualization of SYNPO2 homo-dimer using BIFC and FACS-BIFC based assay 
In order to investigate and to visualize the SYNPO2 dimerization in living cells, HEK293 
cells were transiently transfected with 300 ng ΔN-YFP-SYNPO2/ΔC-YFP (Fig. 28A), ΔN-
YFP/ΔC-YFP-SYNPO2 (Fig. 28B) as controls or ΔN-YFP-SYNPO2/ΔC-YFP-SYNPO2 (Fig. 28C). 
Confocal fluorescence images of control HEK293 cells did not demonstrate any detectable 
fluorescence. However, cells transfected with ΔN-YFP-SYNPO2/ΔC-YFP-SYNPO2 showed a 
cytoplasmic accumulation of SYNPO2-dimers. Interestingly, SYNPO2-dimers were 
detected close to the cell membrane and also nucleus membrane (Fig. 28C, white arrow). 
FACS analysis of cells transfected with ΔN-YFP-SYNPO2/ΔC-YFP-SYNPO2 demonstrated an 
approximately 12% of cells which are fluorescence positive (Fig. 28D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28 Imaging of self-association of SYNPO2 to form homo-dimers in living cells. Confocal fluorescence 
analysis of transiently cotransfected HEK293 cells with 300 ng of ΔC-YFP/ΔN-SYNPO2 (A), ΔC-SYNPO2/ΔN-
YFP (B), and ΔC-SYNPO2/ΔN-SYNPO2 (C) using the calcium phosphate method. FACS quantitative analysis of 
BIFC-SYNPO2 homo-dimerization is presented in the Dot-plot (D) and the histogram (E). Scale bars present 
20 µm 
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4 Discussion 
 
4.1 Current state of knowledge as relevant to this work 
VSMCs show a unique behavior that allows them to modulate their phenotype due to 
(de)differentiation 10, 12 and upon diseases like arteriosclerosis, high blood pressure and 
during vascular injuries 11, 13, 40. Notably in response to vascular injury, VSMCs dramatically 
increase their rate of proliferation, migration, and synthetic activity and therefore play an 
essential role during vascular repair. Unfortunately this high degree of phenotype 
plasticity could also predispose the cells to abnormal environmental cues and signals that 
can lead to various adverse phenotype switches and in turn development of different 
vascular diseases. Additional examples of diseases associated with phenotype switch are 
cancer152, asthma153, obstructive bladder disease154, and numerous gastrointestinal 
pathologies155. Thus, the major challenge in understanding differentiation of the VSMCs is 
that these cells can exhibit a wide range of different phenotypes at different stage of 
tissue development and diseases. Accordingly, this is essential to advance our 
understanding of the mechanisms controlling VSMCs phenotype switch in health and 
disease. Several studies have provided evidence of the crucial role of the cytoskeleton 
and smooth muscle marker proteins during tissue development, cell (de)differentiation, 
phenotype switch, and various vascular diseases 40, 156. The marker proteins for 
differentiated smooth muscle cells with the highest relevance are αSMA157, smMHC158, 
smoothelin159, hCaD160, sm22161, and CaLP162 proteins, which are mostly down-regulated 
during the phenotype switching from a contractile to a synthetic phenotype 40, 41, 156 
(Table 20). 
 
 
 
 
 
Table 20 Alteration of the marker proteins expression level in the smooth muscle cells during phenotype 
switch and/or diseases (Summarized according to Sobue et al. 1998 & 1999).  
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Furthermore, it has been reported that mechanotransduction affects phenotype 
modulation, whereby mechanical stimuli regulates target proteins or genes 8, 163, 164. The 
sequence of events is initiated with the stimuli arising from the interaction of 
extracellular matrix proteins with the integrins protein family, which in turn passes the 
stimuli on to focal adhesion complexes165, 166. Afterwards the stimuli are transmitted to 
the cytoskeleton, leading to a remodeling of actin and quantitative changes of VSMC 
marker proteins 163, 164. Actin is the most abundant protein in eukaryotic cells. Depending 
on its localization in the cell, it forms different cytoskeletal structures and plays different 
functions. Thus, actin plays crucial roles in processes such as the establishment of cellular 
shape, cell motility, cell adhesion, muscle contractility, differentiation, transcription, 
cytokinesis, and the formation and maintenance of neuronal synapses. Accordingly, actin 
dysfunction and mutations can be involved in to countless diseases, including muscle 
myopathies167, cancer168, Alzheimer’s169, 170, Wiskott-Aldrich syndrome164, and neuronal 
retardation171. The structures of actin networks and their cellular functions are regulated 
by other hundreds of cytoskeletal proteins, generally known as actin binding proteins 
(ABPs). ABPs regulated elongation, shortening, capping or uncapping of the actin 
filaments as well as the formation of bundles and branches56. While the functions of some 
of these proteins are known, the physiological functions of newly discovered ABPs still 
remain unclear. One of these recently identified ABPs is synaptopodin 2 (SYNPO2), a 
member of the synaptopodin family75, 77, 88, 92.  
SYNPO2 is an actin nucleator and actin filament binding protein75, 88, 172. Its close 
association with actin links SYNPO2 to the reorganization of the actin cytoskeleton and 
therefore to differentiation aspects involved in phenotype modulation. Previous studies 
showed that SYNPO2 (murine GFP-myopodin) shuttles between the cytoplasm and the 
nucleus during differentiation and heat shock in striated muscle and cardiomyocytes77, 100, 
101. SYNPO2 is also a tumor suppressor protein and its shuttling has also been reported in 
carcinogenesis and metastasis of bladder and prostate cancer94, 95. The Mundel laboratory 
reported that the loss of nuclear expression of SYNPO2 in bladder cancer predicts the 
clinical outcome. In differentiated cells and during carcinogenesis SYNPO2 is accumulated 
in the cytoplasm while in the non-differentiated cells and after application of heat shock 
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SYNPO2 was mainly in the nucleus80, 94. Although many reports discussed a crucial role for 
SYNPO2 in striated muscle and cancer cells, the role of SYNPO2 in VSMCs is so far 
unknown. 
With this notion that SYNPO2 is a part of the ABP-complex and therefore may be involved 
in the regulation of cell differentiation, phenotype switch of VSMCs and regulation of 
vascular tones, we have focused on the subcellular localization and expression level of 
endogenous SYNPO2 under conditions that promoted a differentiated versus 
dedifferentiated vascular smooth muscle phenotype. Therefore, the goal of this proposal 
was to address this lack of understanding, by using a multi-disciplinary approach, 
spanning cell through molecular biology. This research will considerably advance our 
understanding of the mechanisms controlling SYNPO2 dynamic and functions in cells in 
health and disease. 
 
4.2 Phenotype switch of VSMCs affects the subcellular distribution of SYNPO2 
In order to elucidate the relation between SYNPO2 and the phenotype switch of VSMCs, 
cells were freshly isolated from rat aorta131 and characterized using anti-CD90 directed 
against fibroblast and specific smooth muscle marker antibodies like anti-smMHC, anti-
desmin, and anti-α-SMA (Fig. 9). Isolated VSMCs demonstrated strong expression of all 
three smooth muscle marker proteins, while less than 3% positive signal was detected 
when cells treated with anti-CD90 antibody. A coimmunostaining of SYNPO2, α-SMA, and 
smMHC showed a strong colocalization of SYNPO2 and α-SMA (Fig. 10 B), while 
colocalization of SYNPO2 and smMHC was found to be diffuse (Fig. 10 A). This result may 
suggest that the binding of SYNPO2 to actin seems to be direct while its binding to myosin 
is an indirect inteaction which is controlled by actin. In addition, VSMCs were 
characterized based on the expression of marker proteins, characteristic for a contractile 
or a non-contractile phenotype (Table 20). Consistent with the known literature41, 156, we 
found high expression levels of contractile markers on the first day of cell preparation. 
The phenotype was assessed by determination of markers of contractile and synthetic 
phenotype by qRT-PCR and Western Blotting. Our results revealed high expression levels 
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of contractile markers like sm22, Smtn, and hCaD, on the first day of cell preparation 
while the expression of these markers rapidly decreased accompanied by the up-
regulation of markers favored by the synthetic phenotype like lCaD during cultivation (Fig. 
11)173. In respect to SYNPO2 we found a mild, but significant down-regulation (~1.4 fold, 
p<0.01) of transcript levels with increasing cultivation time (Fig. 11 A). However, confocal 
microscopy and subcellular fractioning combined with Western blotting revealed more 
striking results (Fig. 12). These demonstrated different distribution of SYNPO2 isoforms in 
the nucleus compared to cytoplasm and total cell lysis (Fig. 12D). A possible reason for 
this could be specific subcellular differences in the distribution of SYNPO2 isoforms in the 
cell nucleus versus in the cytoplasm. During cultivation of VSMCs, SYNPO2 changed its 
subcellular localization from the cytoplasm, on day 1 (contractile), to the nucleus, on 
passage 2 (Fig. 12A & B). The quantitative analysis of the subcellular localization of 
SYNPO2 based on indirect immunofluorescence data showed that on the day 1 of 
isolation, SYNPO2 was detected in 16% of the isolated cells in the nucleus, but in the 
majority of the cells SYNPO2 was localized into the cytoplasm. In contrast, at passage 2, 
SYNPO2 was located in the nucleus of 89% of the cells (Fig. 12 C).  
Furthermore, to obtain a better insight into the mechanisms that regulate shuttling of 
SYNPO2, the phenotype rescue from non-contractile to the contractile phenotype was 
analyzed. The exctracellular matrix (ECM) protein laminin has been shown to activate 
pathways involved in the formation of a contractile phenotype8, 146, while collagen I favors 
signaling leading to a dedifferentiated phenotype8, 34, 174. Thus, we applied conditions that 
promoted the development of a differentiated versus a dedifferentiated phenotype in 
VSMCs using laminin and collagen I. In order to avoid the very rigid matrix of a cell culture 
dish, a polyacrylamide matrix with a stiffness of 55 kPa, as found during atherosclerosis, 
was chosen as the cell culture basement.  
Analysis of the cells by Western blotting, qRT-PCR, light microscopy, and confocal 
microscopy showed, in agreement with others8, 34, 146 that laminin induced a 
differentiated phenotype in VSMCs (Fig. 13). However, VSMCs cultivated on collagen I 
mainted the dedifferentiated phenotype (also known as synthetic phenotype)174. In term 
of subcellular localization of SYNPO2, cells cultivated on collagen I showed an increased 
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accumulation of SYNPO2 in the nucleus (Fig. 14 A), while cultivation on laminin led to 
cytoplasmic localization of SYNPO2 with a significance level of p< 0.001 (Fig. 14 B). 
Notably, beside to the cytoplasmic localization of SYNPO2 on laminin coated matrices, an 
up-regulation of SYNPO2 by more than 3-fold could be observed (Fig. 13 A). Based on the 
expression rates of SYNPO2 during isolation and cultivation on untreated culture dishes 
an upregulation to this extend was unexpected.  
Interestingly, apart from reduction of SYNPO2 expression in non-contractile VSMCs and 
an up-regulation in laminin-treated VSMCs, these findings resemble the results reported 
before for striated muscles77. For example, a cytoplasmic localization of SYNPO2 in C2C12 
cells has been described during differentiation from myoblasts to myotubes77. In the 
latter ones upon differentiation SYNPO2 was found in Z-lines77, 101, a structure closely 
related to smooth muscle dense bodies175. In vivo avian SYNPO2 (fesselin) has been 
shown to localize to the dense bodies in the gizzard97. Shuttling of SYNPO2 upon cell 
differentiation seems to be not only conserved but also important. For instance, under 
pathological conditions of urinary bladder and prostate cancer, subcellular localization of 
SYNPO2 is crucial for the clinical outcome94. A benign prognosis is associated with a 
nuclear localization and unchanged expression rates of SYNPO2, while a malignant 
outcome goes along with reduced expression and depletion of nuclear SNYPO278, 94, 95. 
We have now detected for the first time under non-pathological condition a change in 
subcellular localization of SYNPO2 that is correlated with a change in expression level (Fig. 
13 A). We found an upregulated expression rate of SYNPO2 in VSMCs upon phenotype 
switching from a non-contractile (proliferative phenotype) to a contractile phenotype 
(Fig. 13 A). This finding could explain the suppressor effect of SYNPO2 on proliferative 
phenotype compared to previous works, describing invasive cells in bladder and prostate 
cancer80, 94. However, the function of the increased SYNPO2 expression associated with its 
cytoplasmic accumulation as observed in differentiated VSMCs, is so far unknown. 
Possible reasons for this controversial results in terms of subcellular localization of 
SYNPO2 in VSMCs, compared to bladder and prostate cancers, could either be cell type-
specific differences in the impact of SYNPO2 on the regulation of differentiation state in 
invasive cells and in VSMCs or variable experimental settings.  
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Taken together, these findings raised the hypothesis of a potential link of SYNPO2 
trafficking as ABP and differentiation states of cells. We may conclude that the phenotype 
switching of VSMCs correlates with the subcellular localization and expression level of the 
novel ABP SYNPO2 via mechanisms involving VSMCs differentiation due to extracellular 
matrix components like laminin, as contractile inducer and collagen I, as non-contractile 
regulator, which still remains to be elucidated.  
 
4.3 Actin dynamics and subcellular distribution of SYNPO2 in VSMCs 
There is increasing information that SYNPO2 increased nucleation and polymerization of 
actin75, 89, 90, 97-99, 176 and therefore it is a part of the actin cytoskeleton complex. 
Accordingly, the so far best studied function of SYNPO2 is its effect on the actin 
cytoskeleton76, 90, 99, 176. In order to test whether this interaction is reciprocal and 
participates in phenotype switching, depending on an operating SYNPO2 shuttling, we 
manipulated the actin cytoskeleton. Cytochalasin D (CCD) and jasplaklinolide (JASP) are 
small components that are supposed to destabilize or stabilize, respectively, the actin 
cytoskeleton177, 178. The main difference of SYNPO2 distribution was observed in cells 
seeded on ECM protein-coated polyacrylamide matrices. We detected a nuclear 
localization of SYNPO2 when collagen I was used (Fig. 15 A) and a cytoplasmic distribution 
when VSMCs were cultivated on laminin (Fig. 15 E). As long as stress fibers were still 
intact, we still observed SYNPO2 in the nucleus when seeded on a collagen I coated 
matrix and in the cytoplasm, when cells were seeded on a laminin-coated matrix 
compared to control cells. The biggest effect has been observed on collagen I matrices 
with CCD, where nuclear localization of SYNPO2 was not as intense as in cells that were 
treated with the vehicle control or JASP (Fig. 15 B and C). In the case of laminin coating, 
cells showed in the presence of CCD a stronger accumulation of SYNPO2 in the nucleus 
(Fig. 15 F). The effects of JASP were more subtle and resembled those that were observed 
with the vehicle control (Fig. 15 G). However, a manipulation of the actin cytoskeleton, as 
evident by the formation of phalloidin-blisters, could only be observed when CCD was 
applied (Fig. 15 B and F). As a refutation, one could argue that cells might have already 
adhered when treated with CCD or JASP, and SYNPO2 might have already occupied its 
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final destination. However, this argument does not comply with a dynamic actin 
cytoskeleton. So, when the drugs were applied, the cells had already settled and 
developed actin stress fibers, SYNPO2, as an actin-binding protein, underlies a dynamic 
process as actin itself. However, the effect of SYNPO2 on the actin cytoskeleton and vice 
versa may be mutual. We assumed that the effect SYNPO2 has on the actin cytoskeleton 
is stabilization of F-actin75. In this case the presence of SYNPO2 in the cytoplasm may shift 
the F-actin/G-actin-ratio and control the actin that enters the nucleus and participates in 
transcription. With the notion that in VSMCs, up to 25% of actin exists as G-actin175, the 
F/G-actin ratio was determined using a G-actin/F-actin kit (Cytoskeleton) to indicate 
whether the F/G-actin ratio underlies the changes during differentiation of the VSMCs. 
VSMCs grown on laminin or collagen I-coated polyacrylamide matrices demonstrated the 
same F/G-actin ratio in response to the CCD and JASP as compared to the vehicle controls 
(Fig. 15). In case of VSMCs (passage 3) cultivated on laminin and treated with JASP, 
SYNPO2 was accumulated in the cytoplasm as compared to vehicle control and CCD 
treated cells (Fig. 15 G). However, incubating the VSMCs cultivated on collagen I with 
JASP did not affect the subcellular localization of SYNPO2 (Fig. 15 C), while the F-actin 
ratio was increased (Fig. 15 D). Possible reasons for these controversial results could 
either be cell phenotype-specific differences in the impact of JASP on actin polymerization 
in VSMCs and consequently SYNPO2 shuttling, or differences in the impact of laminin 
versus collagen I by so far unknown mechanism. 
Previous reports have shown that heat stress regulates gene expression, controls 
synthesis of heat shock proteins and induces changes in morphology of nucleoli, 
cytoplasmic organelles, and actin cytoskeleton179, 180. Notably, it is already reported, that 
heat shock inhibits actin polymerization and therefore affcets actin cytoskeleton 
dynamics181. However, there always exists an exception to the rule. Recently, heat-
induced stress (43°C) has been reported to affect the subcellular localization of murine 
SYNPO277, 101. These observations were only reported in C2C12 cells transfected with a 
GFP-fused murine SYNPO2. Because the shuttling of GFP-SYNPO2 could be due to the 
diffusion of the GFP through the nuclear pores182, 183 the subcellular localization of 
SYNPO2 in VSMCs was investigated by means of specific antibodies directed against the 
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endogenous protein. In contrast to results that were obtained in cardio myocytes and 
skeletal muscle cells, using fusion-proteins of GFP-SYNPO277, stress applied in the form of 
heat shock did not trigger shuttling of SYNPO2 to the nucleus (Fig. 16). Possible reasons 
for this controversial results could either be cell type-specific differences in the impact of 
heat shock stress on distribution and function of SYNPO2 or variable experimental 
settings. 
There is increasing evidence about the crucial roles of Rho-GTPase signaling pathways in 
the cell functions and especially its role in smooth muscle contraction, and actin 
organization16, 105, 184, 185. The roles of the GTPase Rho and its downstream effectors, the 
Rho-associated protein serine/threonine kinase (ROCK) family, have been intensively 
studied. Many studies point to the significant regulatory roles of the Rho-ROCK signaling 
pathway in various cellular functions like actin cytoskeleton organization105, 186, 
cytokinesis, cell motility187, contraction of the smooth muscle cells (Fig. 29), and vascular 
contraction16, 188-190.  
 
 
 
 
 
 
 
 
 
Fig. 29 Schematic illustration of actin cytoskeleton dynamics depending on Rho-Rock signaling pathway 
(modified from Alan Hall, science, 1998). The Rho-associated kinase as a main downstream effector protein 
of the small GTPase Rho, plays different crucial roles in the cells and is one of the major regulators of 
cytoskeleton. Rock inhibits de-polymerization of actin filaments indirectly by phosphorylation and activation 
of LIM kinase, which in turn phosphorylates cofilin, and therefore stabilizes actin filaments. 
 
The Duncan Laboratory showed that SYNPO2 can promote cell migration via activation of 
Rho-ROCK signaling pathway191. SYNPO2 has been shown to affect cell migration in 
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response to different chemokinetic stimuli (NIH 3T3 CM or 10% FBS as chemo-
attractants), which in turn was dependent on Rho-ROCK signaling that regulates the actin 
cytoskeleton and in turn the cell migration191. The NIH 3T3 conditioned medium (CM) 
activate Rho-Rock signaling pathway and therefore it promotes migration of PC3 cells 
(embryonal carcinoma cells) while FBS demonstrates a modest effect on this pathway.  
Therefore, in order to elucidate the role of Rho-ROCK signaling pathway for SYNPO2 
trafficking in the VSMCs, cells were treated with a commercial inhibitor (Y27632) directed 
against Rho-associated protein serine/threonine kinase (ROCK) as a downstream effector 
of Rho-GTPase signaling pathway. Treatment the VSMCs from passage 3 (non-contractile 
phenotype) with Y27632 disrupted actin cytoskeleton as reported before, but this 
disruption of actin cytoskeleton was not accompanied by alteration of the subcellular 
distribution of SYNPO2 (Fig. 19). Previous studies showed that the inhibition of Rho-ROCK 
signaling pathway results in the inhibition of cell polarization, lamellipodia formation, and 
in turn cell migration192-194. Why inhibition of ROCK does not effect on distribution of 
SYNPO2 is unclear. As described before a major challenge in understanding 
differentiation of VSMC is that the cells exhibit different phenotypes at different stages of 
development and especially in cell culture condition. Accordingly, possible reasons for 
this result could either be cell phenotype differences in the impact of the cell culture or 
variable experimental settings. 
 
4.4 The cAMP mediated signaling is involved in the subcellular shuttling of 
SYNPO2 between the nucleus and the cytoplasm  
Recently, several studies showed that murine SYNPO2 altered its subcellular localization 
between the cytoplasm and the nucleus due to its phosphorylation status77, 96, 100, 101. In 
vitro studies demonstrated a crucial role of PKA and CaMK-II during this process, in which 
SYNPO2 was first phosphorylated on two 14-3-3 binding motifs100. In vitro 
phosphorylation studies of murine SYNPO2 showed that PKA phosphorylated the both 
binding sites, while CaMK-II phosphorylated only one of the binding sites100. These results 
suggest that cAMP-dependent signaling pathways like the PKA pathway (not shown for 
VSMCs) as the main controlling pathways for the functions of SYNPO2 in the cells (Fig. 
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30). Until now, most investigations on SYNPO2 were performed in striated muscle cells 
like skeletal and cardiac muscle77, 100, 101 and in bladder or prostate cancers78, 80, 94, 95. Most 
information about the role of SYNPO2 is limited to these tissues, and therefore its role in 
vascular muscle systems and notably in the vascular smooth muscle cells are completely 
unclear. Thus, more information about this shuttling in VSMCs will considerably advance 
our understanding of the mechanisms controlling SYNPO2 functions and in turn actin 
dynamics in cells in health and disease.  
The cAMP-dependent pathways is a G-protein-coupled receptor-triggered signaling 
cascade. As described before, an increase in the cAMP level leads to the activation of PKA, 
a cAMP dependt protein kinase, and EPAC, a cAMP-regulated guanine nucleotide 
exchange factor (GEF) 16, 195. In this case, the activated α-subunit of the G protein binds to 
and activates adenylyl cyclase (AC), which, in turn, catalyzes the production of cyclic 
adenosine monophosphate (cAMP) from ATP. The produced cAMP activates the cAMP-
dependent pathways like PKA and EPAC. These pathways can either be activated directly 
by stimulation of adenylyl cyclase, PKA and EPAC196, or by blocking the phosphodiesterase 
using commercial small molecules. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30 Schematic illustration of PKA (R= regulatory domain, C= catalytic domain) and CaMKII-dependent 
phosphorylation of SYNPO2 used in this work (modified from Faul et al. 2007). 
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To provide more mechanistic insides, it was investigated, whether PKA and CaMKII could 
control the subcellular distribution of SYNPO2 in VSMCs. In order to investigate the 
effects of cAMP levels and also cAMP dependent signaling pathways, VSMCs were treated 
with different components. Interestingly, increased cAMP levels in VSMCs (day 1 of 
isolation) induced accumulation of SYNPO2 in the nucleus as described before100, when 
adenylyl-cyclase was directly activated by forskolin, Sp-5.6-DCl-cBIMPS and urocortin as 
activators (Fig. 17 B-D). Furthermore, the treated VSMCs with these activators 
demonstrated an increase in the numbers of nuclear SYNPO2-displaying cells in 
comparison with vehicle cells (Fig. 17 F). A combination of forskolin as activator for 
adenylyl cyclase and IBMX as an inhibitor for PDEs, resulted a reduction of nuclear 
SYNPO2-displaying cells (Fig. 17 E & F) and a diffuse localization of SYNPO2 around the 
nucleus. A possible mechanism for the decreased nuclear SYNPO2-displaying cells could 
be that increased cAMP levels activate an alternative cAMP-mediated pathway like EPAC 
which may affect export of SYNPO2 from the nucleus by a so far unknown mechanism.  
Furthermore, to assess the functionality effect of the PKA and CaMKII on SYNPO2 
trafficking, VSMCs form passage 3 (SYNPO2 in the nucleus) were treated by inhibitors 
directed against PKA and CaMKII. The inhibition of PKA with H89, Rp-8-PIP-cAMPS 
demonstrated a stronger reduction of nuclear SYNPO2 as compared to the VSMCs in 
which CaMKII was inhibited with KN93 (Fig. 18). This may be explained by the fact that 
the PKA phosphorylated both threonine, and serine, while CaMKII phosphorylated only 
threonine100 on 14-3-3 binding motifs.  
Phosphorylation/de-phosphorylation of proteins regulated by protein kinases and 
phosphatases, affects one third of all proteins in the cells, which in turn control numerous 
cellular processes197, 198. Our data suggest that the activation of CaMKII and PKA by an 
increased concentration of cAMP could affect subcellular localization of SYNPO2. 
Therefore, it was essential to investigate whether phosphatases affect subcellular 
localization of SYNPO2. Accordingly, VSMCs were treated with Okadaic acid (OA), which 
inhibits protein phosphatase 1 (PP1, IC50 = 3 - 15 µM) and protein phosphatase 2A (PP2A, 
IC50 = 0.1-1 nM) specifically199, 200. Interestingly, we detected that the inhibition of 
phosphatases causes an accumulation of SYNPO2 in the cytoplasm and around the cell 
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nucleus (Fig. 20). On the one hand, this result may suggest that the phosphorylated forms 
of the SYNPO2 are essential for its shuttling in both directions (cytoplasm ↔ nucleus), 
which in turn could also be crucial for its regulation in the both cell nucleus and the 
cytoplasm. PP2A is a trimeric holoenzyme that acts as a tumor suppressor. A number of 
studies showed that the OA inhibits PP2A and therefore it promotes tumor growth and 
invasion201, 202. Therefore, it can be speculated that the inhibition of PP2A by OA, which 
causes a migrative phenotype, and in turn also phosphorylation of SYNPO2 in the nucleus 
may regulate the loss of nuclear SYNPO2. On the other hand, unfortunately the 
concentration that we used, 100 nM OA, inhibits only PP2A in VSMCs and not PP1. So far, 
it is not clear how the PP1 is communicated to the SYNPO2 shuttling, but one hypothesis 
is that it works independently of the PP2A, directly dephosphorylating SYNPO2, which in 
turn causes cytoplasmic accumulation of SYNPO2 in VSMCs via a so far unknown 
mechanism. 
  
4.5 Imaging of SYNPO2, 14-3-3γ/β, and Importinα interaction in living cells 
Phosphorylation as a post-translational modification (PTM) affects approximately one 
third of all proteins in the cell198, 203. 14-3-3 interactions with phosphorylated parts 
(RSXpS/TXP, phospho-serine or -threonine) of different proteins were a way to read this 
PTM in signaling cascades. 14-3-3 proteins form hetero- and homodimeric structures that 
bind to a large number of phosphorylated signaling proteins and control their nuclear and 
cytoplasmic distribution204-206. Moreover, It is widely accepted today that the binding of 
14-3-3 proteins to disorder proteins is crucial for their stabilization, activity and especially 
protein-protein interactions206-208. 
One novel class of such proteins is SYNPO2, which belongs to the natively unfolded 
proteins172. It has been recently reported that 14-3-3 polypeptides, acting as chaperone-
like adaptor proteins, are able to bind a specific sequence of SYNPO2101, which in turn is 
crucial for the shuttling of SYNPO2 from the cytoplasm into the nucleus as shown for 
striated muscle cells96, 101. This could of course also imply a functional relevance of 14-3-3 
isoforms at the differentiation state of VSMCs and in turn also for the trafficking of 
SYNPO2. However, no reports are currently available to test the functionality of the 14-3-
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3 isoforms experimentally in this term. Accordingly, to test this, the expression levels of 
seven 14-3-3 isoforms were analyzed using quantitative real-time PCR. As shown in Fig. 
21, the mRNA level of the 14-3-3τ, η, and ζ were more abundant on the first day of 
isolation than at passage 3, while the mRNA level of isoform σ was higher at passage 3. 
The significance level of 14-3-3η expression was p<0.02 as determined by a two-tailed 
student’s t-test. For 14-3-3τ, and isoform ζ the significance was p<0.001. We found a 
higher expression of 14-3-3σ upon dedifferentiation of VSMCs with a significance level of 
p<0.005. Interestingly, no significant changes in mRNA level of the isoforms β, γ, ε was 
detected at passage 3 in VSMCs compared to cells from day 1.  
Although no conclusive results could be shown for the 14-3-3 isoforms β, γ during 
phenotype switch, three arguments suggest that probably both, 14-3-3β, and -γ, act 
together in the trafficking of SYNPO2 in VSMCs during its phenotype modulation: first, 
several studies showed that interaction of SYNPO2 with 14-3-3β leads to its accumulation 
in the nucleus of C2C12 cells100, 101; second, it is already reported that of the seven 
isoforms comprising this family, 14-3-3γ and -β are highly expressed in VSMCs147-150; and 
finally, it has been previously reported that the oxidation of 14-3-3γ by a PDGF mediated 
pathway induces VSMC migration209. So far, nothing is known about the function of 
different 14-3-3 isoforms in VSMCs in term of subcellular trafficking of SYNPO2, which 
could also be important for the phenotype switch, disease and beyond. 
Furthremore, this import into the nucleus of cells is dependent on a signal, in the form of 
nuclear localization sequences (NLSs), cytosolic factors, binding to the nuclear pore, and 
subsequent translocation through the nuclear pore. The G protein Ran/TC4210, 211 and an 
interacting partner, importinα212 were found to be the active components of the cytosolic 
factors that are implicated in the nuclear-cytoplasmic shuttling of SYNPO2. This synergy 
strongly depends on the phosphorylation form of SYNPO2 as shown by in vitro 
experiments100. Nevertheless, this evidence required more physiological information 
about these proteins in the cellular context. Accordingly, we next investigated the 
subcellular localization of SYNPO2, 14-3-3γ/β, and importinα and their interaction 
together in living cells by designing and combining different fluorescent proteins (Fig. 22 
A and B). 
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Modern fluorescence techniques like FRET, FACS and BIFC assay have emerged as the 
most promising techniques to study the subcellular localization and protein-protein 
interaction studies in living cells118, 125, 126. This included the incorporation of different 
fluorescent dyes at different positions in the proteins of interest, in case of FRET (Fig. 5) 
and/or different non-fluorescent fragments in the proteins of interest , in case of BIFC 
assay (Fig. 6). Although, FRET is a powerful method for colocalization and protein-protein 
interaction studies, its limitations include the crucial distance ~ 10 nm, and the choice of 
the best sites for ligation of fluorescent proteins remains a significant challenge117, 122. 
Therefore optimizing and characterizing the best FRET constructs can be time-consuming. 
In this work, various fluorescent conjugated proteins, such as 14-3-3γ/β, Importinα, and 
SYNPO2 were used. These provided insights into the molecular mechanism of protein-
protein interactions, between SYNPO2 and its partners, in living cells. Since it could be 
difficult to interpret and to predict whether the resulted fluorescence displays an 
interaction between two and more proteins or subcellular localization, two different 
fluorescence-based assays such as common fluorescence imaging and BIFC assays in 
combination with FACS analysis were used.  
SYNPO2 alters its subcellular localization during differentiation, heat shock stress (not 
detected in VSMCs), and also during smooth muscle phenotype modulation (see 4.2). 
Even though the precise function in the cellular context remains to be elucidated, it likely 
involves the actin polymerization and complex formation of SYNPO2 with 14-3-3γ or β 
and the importinα during shuttling between the cell cytoplasm and the nucleus (Fig. 31).  
Accordingly, these findings raised the hypothesis of a possible ternary complex formation 
of SYNPO2/14-3-3γ/importinα or SYNPO2/14-3-3β/importinα with actin in the nucleus. 
Since the shuttling action of SYNPO2 should itself be tightly regulated, we established a 
BiFC-based assay that allows the visualization of SYNPO2-14-3-3γ and β, and importinα 
complexes and their quantification by confocal microscopy and FACS analysis. With these 
techniques, the subcellular localization of SYNPO2, 14-3-3γ/β and importinα, and the 
regulatory effects of 14-3-3γ/β and importinα on the SYNPO2 shuttling can be analyzed in 
a cellular context fashion.  
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Fig. 31 Schematic illustration of nuclear-cytoplasmic trafficking of SYNPO2 (According to Faul et al. 2005). 
PKA and CaMKII phosphorylate SYNPO2 in both 14-3-3 binding motifs. These phosphorylations affect 
dissociation of α-actinin and actin from SYNPO2, which in turn allow its interaction with 14-3-3. Finally, 
SYNPO2-14-3-3 complex forms a ternary complex with importinα, which govern SYNPO2 transport to the 
nucleus.  
 
In order to provide flexibility for independent motion of the fluorescent protein 
fragments and the interaction partners, N-terminal CFP fused proteins, with a SGLRS-
linker, between CFP and the protein of interest were used. The GSAPVAT-linker was used 
for C-terminal conjugated CFP and to design C-terminal and N-Terminal conjugated YFP 
proteins, SGLRSRA and GSRPVAT were used between YFP and the proteins, respectively 
(Fig. 22 A). In order to generate BIFC constructs with high fluorescence yield and minimal 
background several plasmid variants with RSITLAAA-linker were used (Fig. 22 B). Western 
blot analysis of fluorescent and non-fluorescent fragments-fused constructs 
demonstrated expected molecular weight for each protein (Fig. 23).  
In terms of subcellular localization of SYNPO2, 14-3-3β/γ, and importinα, our 
conventional fluorescent fused constructs demonstrated a nuclear localization for 
SYNPO2, and importinα, while 14-3-3γ and 14-3-3β accumulated mainly in the cytoplasm 
(Fig. 24). Interestingly, we found the same nuclear distribution in distinct actin loop form 
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as it is reported for murine SYNPO2 fused to GFP (Fig. 24 A, white arrow)77. Transiently 
transfected cells with CFP-importinα, importinα-CFP, and YFP-SYNPO2 demonstrated also 
nuclear bodies-like structures for importinα (Fig. 24 G to H´) and SYNPO2 (Fig. 24 A´) by so 
far unknown functions. 
In order to investigate the physical interaction between SYNPO2, 14-3-3β/γ, and 
importinα in the cellular context, it was verified whether both ΔN-YFP-SYNPO2 and ΔC-
YFP-SYNPO2 interact with ΔN-, ΔC-YFP fused 14-3-3β/γ and importinα based on 
fluorescence development according to the BIFC assay. The BIFC method offers a 
simultaneous visualization of multiple proteins interacting in the living cells130. Confocal 
fluorescence images from the HEK293 cells transfected with ΔC-YFP-14-3-3γ/ΔN-YFP-
SYNPO2 and ΔC-YFP-SYNPO2/ΔN-YFP-14-3-3γ demonstrated an interaction between 
SYNPO2 and 14-3-3γ in the cytoplasm (Fig. 25 B & D). We detected that the cells 
transfected with ΔC-YFP-SYNPO2/ΔN-YFP-14-3-3γ displayed highly punctuated pattern of 
structures in the cytoplasm (Fig. 25 D). In contrast to the 14-3-3γ, a nuclear localization of 
SYNPO2 was detected when a combination of ΔC-YFP-SYNPO2/ΔN-YFP-14-3-3β and ΔC-
YFP-14-3-3β/ΔN-YFP-SYNPO2 was used (Fig. 26 B & E). A possible mechanism could be 
that the interaction of SYNPO2 with 14-3-3γ stabilizes its localization in the cytoplasm, 
while it’s shuttling to the nucleus seems to be regulated by 14-3-3β. Moreover, we 
detected protein aggregation-like structure in the nucleus (Fig. 26 B), which may either 
occur due to overexpression of constructs or display a form of nuclear bodies with so far 
unknown function. Furthermore, we detected a nucleus colocalization of SYNPO2-14-3-3β 
complex in form of a loop structure in the nucleus (Fig. 26 C´).  
Murine SYNPO2 contains two putative NLSs that are crucial for the nuclear import of 
myopodin. According to the notion that the selective import of proteins into the cell 
nucleus is depending on (A) the presence of NLSs and (B) the interaction of importinα 
with NLSs, SYNPO2, importinα interaction was investigated using BIFC assay. Confocal 
fluorescence images of transiently transfected HEK293 cells with ΔN-YFP-SYNPO2/ΔC-YFP-
Importinα and ΔC-YFP-SYNPO2/ΔC-YFP-Importinα demonstrated a nuclear accumulation 
of both proteins. Moreover, we found the same nuclear loops as described above for YFP-
SYNPO2 (Fig. 24 A) and ΔC-YFP-SYNPO2/ΔN-YFP-14-3-3β (Fig. 26 E) when the cells were 
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transfected with ΔN-YFP SYNPO2/ΔC-YFP-Importinα and ΔC-YFP-SYNPO2/ΔC-YFP-
Importinα (Fig. 27 B & E).  
Interestingly, apart from nuclear localization and interaction between SYNPO2, 14-3-3β, 
and importinα, our findings may resemble the results reported before for actin 
polymerization in the nucleus213, 214. As described before, actin filaments and actin 
binding proteins (ABPs) are involved in different cytoplasmic processes like defining the 
cell shape, cell motility, cytokinesis, and intracellular transport. However, recently actin 
and ABPs have been also assigned numerous functional roles in the nucleus215. 
For instance, works from Christian Baarlink et al.213 and Kei Miyamoto et al.214 suggests an 
essential role of nuclear actin polymerization in cell fate and cellular programming via SRF 
(serum response factor) and Oct4 (octamer-binding transcription factor 4) signaling. SRF 
is a transcription factor that plays essential role in numerous cellular functions like 
regulation of differentiation, cell adhesion, motility and contraction8, 12. Oct4 is a 
transcription factor that is critically involved in the cell division of embryonic stem cells. 
Oct4 is also strongly expressed in the numerous cancers216, 217. Taken together, our 
findings raised the hypothesis of a potential link of SYNPO2, polymerization of nuclear 
actin and signaling involved in health (e.g. cellular development) and diseases (e.g. 
atherosclerosis, and cancer). 
 
4.6 Visualization of SYNPO2 homo-dimerizartion using BIFC assay in living cells 
Principally, many proteins form homodimers or homo-oligomers218. Recent studies show 
that protein homo-dimerization or oligomerization is an essential factor in the regulation 
of proteins such as enzymes, ion channels, receptors and transcription factors219. For 
instance, protein dimerization can be a mechanism for activition220 or inhibition221. 
Although, self-association and/or oligomerozation seem to be very common to generate a 
biological response in the cells, it is often difficult to quantify, because the stoichiometry 
of self-association for proteins has not been characterized by robust biophysical methods. 
It is already known that many ABPs either contain two or more actin binding motifs, or 
they interact with actin as a homodimer or oligomer222-224.  
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SYNPO2 is a strong candidate to exhibit such a feature because previous studies showed 
that SYNPO2 regulates actin nucleation, polymerization and further controls cross-linking 
of actin filaments into thick bundles. Furthermore, since SYNPO2 as a novel ABP 
demonstrated a direct interaction with actin92, similar to α-actinin, filamin (actin cross-
linking proteins), it may also play its role as homodimer or/and oligomer.  
Although, recently the Fürst labrotaory reported homodimerization of murine SYNPO2 by 
using biochemical methods92, it has not been a subject in a cellular context study. 
Accordingly, these findings raised the hypothesis of a potential link of SYNPO2 
dimerization and its function in the cells. To address this possible mechanism, HEK293 
cells were transiently transfected with ΔC-YFP-SYNPO2/ΔN-YFP-SYNPO2.  
Our transiently cotransfected HEK293 cells with ΔC-YFP-SYNPO2/ΔN-YFP-SYNPO2 
corroborated the previous finding that the SYNPO2 self-associate in the form a 
homodimer. SYNPO2-homodimer demonstrated a cytoplasmic distribution and not 
nuclear (Fig. 28). Interestingly, SYNPO2-dimers were detected close to the cell membrane 
and also to the nuclear membrane (Fig. 28 C, white arrow). Further quantitative analysis 
of the relative efficiency of BIFC complex formation by using a FACS-BIFC based assay 
demonstrated a significant population of positive BIFC-cells as compared to the cells 
transfected with or without ΔC-YFP/ΔN-YFP (as control experiments). Collectivly, it can be 
speculated that the dimerization of SYNPO2 and its localization at plasma membrane may 
play an autoregulatory effect on its role in cell motility or cell junctions.   
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5 Conclusion and Outlook 
Immunofluorescence, biophysical and molecular approaches not only showed that 
SYNPO2 changed its subcellular localization but also its transcript levels in VSMCs upon 
phenotype switch from contractile to non-contractile. Rat vascular smooth muscle cells 
(rVSMCs) developed a non-contractile phenotype (Passage 3) from contractile cells (day 1 
of isolation) in primary cell culture, which was associated with an accumulation of 
SYNPO2 in the nucleus and a down-regulation of its expression.  
Cultivation of VSMCs (passage 3) on laminin or collagen I coated matrices, induced a 
contractile or a non-contractile phenotype, respectively. This further supported the 
shuttling hypothesis of SYNPO2 depending on a phenotype switch and indicated a 
potential impact of SYNPO2 on phenotype switch.  
Furthermore, the results of this thesis suggest an essential role of the cAMP-regulated 
kinase PKA for the regulation of the SYNPO2 shuttling in VSMCs. Increased cAMP levels in 
VSMCs (contractile) induced accumulation of SYNPO2, when adenylyl-cyclase was directly 
activated by forskolin, Sp-5.6-DCl-cBIMPS and urocortin as activators. Supporting these 
results, inhibition of PKA using specific inhibitors, like H89, Rp-8-PIP-cAMPS demonstrated 
an accumulation of SYNPO2 in the cytoplasm of VSMCs from passage 3. However, we 
detected that the increased cAMP level induced by forskolin and 3-Isobutyl-1-
methylxanthine (IBMX) together caused a diffuse accumulation of SYNPO2 within and 
around the nucleus. In addition, treating the cells from passage 3 with okadaic acid 
demonstrated a reduction in the number of nuclear SYNPO2-displaying VSMCs.  
Possible reasons for these results could be cell type-specific. Differences in the impact of 
cAMP or increased cAMP levels might not only be as pronounced as a PKA-mediated 
trafficking of SYNPO2. As recently reported, cAMP regulates not only the PKA signalling 
pathway, but also EPAC, a cAMP-regulated guanine nucleotide exchange factor (GEF). Like 
PKA, EPAC contains a cAMP binding domain, which activates the small GTPase family 
Rap1 and Rap2. In addition, several studies have shown that the activation of EPAC/Rap 
regulates actin remodeling and adherent junctions. Therefore, it appears that EPAC may 
be involved in SYNPO2 trafficking, due to its role in actin remodeling. Accordingly, a 
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better understanding of the mechanism played by cAMP-mediated pathways during 
SYNPO2 trafficking in the cells is needed. Thus, future experiments using specific and 
selective activators, and/or inhibitors of EPAC should be aimed to elucidate this lack of 
information. 
Furthermore, interaction of SYNPO2 with 14-3-3 and importin-α in the cytoplasm of 
striated muscles regulated its accumulation in the nucleus by so far incompletely 
understood mechanisms. Notably, a BIFC assay demonstrated an increasing fluorescence 
in the nucleus developed after interaction between SYNPO2, 14-3-3β, and importinα as 
well as an enhanced cytoplasmic fluorescence in terms of interaction with 14-3-3γ. In 
conclusion, this indicates that the nuclear accumulation of SYNPO2 could be the result of 
the interaction between SYNPO2 and 14-3-3β and importinα, and not with 14-3-3γ. Up to 
now it is not known which isoforms of 14-3-3 are involved and how is the shuttling of 
SYNPO2 regulated in VSMCs. In this regard, using a SYNPO2 containing mutant 14-3-3 
binding domains and thereby inhibiting the interaction between SYNPO2 and the 
different 14-3-3 isoforms might serve as a better model to study the mechanism that 
regulate trafficking of SYNPO in cells. Further suggested methods would be interaction 
studies using pull-down assays, Immunoprecipitation, BIFC assays, and finally generating, 
14-3-3 knock-out cells to study SYNPO2 trafficking depending on 14-3-3 isoforms.  
Localization of SYNPO2 and its interaction with 14-3-3β in the nucleus of HEK293 cells led 
to the formation of either nuclear dot-like shapes that are similar to the recently reported 
nuclear bodies or loop-like structure. Possible reasons for these observations could either 
be a protein aggregation due to overexpression of SYNPO2 in the nucleus or SYNPO2 
could be involved in the formation of  nuclear bodies and F-actin loops by a so far 
unknown mechanism. Accordingly, some future approaches like co-immunostaining with 
known proteins like perimyelocytic leukemia (PML) which is found in nuclear bodies 
should therefore be performed to elucidate this lack of information.  
The future goal of this project would be to address this lack of understanding by using 
systematic approaches on different levels spanning transcriptional regulation, protein 
level, during development, after injury and under pathological conditions like cancer. For 
instance, embryonic stem cells (ESCs) could be an excellent model to study SYNPO2’s 
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unknown functions because developmental processes in vivo can be recapitulated in vitro 
to a certain extent in a time- and cost-effective manner. 
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